Next Article in Journal
A Novel Direct Butyrate Generator Reduces Belly Pain in a Randomized, Double-Blind, Placebo-Controlled Clinical Study
Previous Article in Journal
Health Benefits of (Poly)phenols from Cherries: A Review of Clinical Trials
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Comparative Assessment of Nutraceuticals for Supporting Skin Health

by
Meike Streker
1,
Ehrhardt Proksch
2,
Jan-Christoph Kattenstroth
3,
Burkhard Poeggeler
4 and
Gunter Lemmnitz
3,*
1
Independent Researcher, 25479 Ellerau, Germany
2
Klinik für Dermatologie, Venerologie und Allergologie, Universität Kiel, 24105 Kiel, Germany
3
QUIRIS Healthcare GmbH & Co. KG, 33334 Gütersloh, Germany
4
Department of Physiology, Johann-Friedrich-Blumenbach Institute for Zoology and Anthropology, Faculty of Biology and Psychology, Georg-August-Universität Göttingen, 37073 Göttingen, Germany
*
Author to whom correspondence should be addressed.
Nutraceuticals 2025, 5(2), 13; https://doi.org/10.3390/nutraceuticals5020013
Submission received: 9 April 2025 / Revised: 28 May 2025 / Accepted: 29 May 2025 / Published: 6 June 2025

Abstract

:
Background/Objectives: The term “nutraceuticals” refers to food and dietary supplements promoted for their health benefits in addition to their nutritional value. These products contain plant- or animal-derived nutrients, vitamins, minerals, trace elements, and similar compounds aimed at enhancing skin health and influencing visible skin quality. This review provides an overview of the current research on nutraceuticals and the scientific evidence supporting their effects on skin health. Methods: The literature on more than 50 selected nutraceuticals was examined to assess any clinically substantiated, beneficial effects on skin health. The assessment was based on scientific evidence, including the quality and quantity of empirically gathered and evaluated findings. Results: A total of 17 common dietary supplements, either as individual compounds or categorized into groups, along with some combination products, were identified as nutraceuticals with well-supported effects on skin health. These include, among others, vitamins A, B7, C, and E; collagen peptides; carotenoids; and various plant extracts. For many other nutraceuticals, clinical evidence for their effects on skin health is limited or insufficient. Conclusions: The literature indicates that many nutraceuticals marketed for skin health are more or less suitable for this application based on the evidence assessment.

1. Introduction

Nutraceuticals represent a modern generation of food and dietary supplements that claim health benefits. To date, numerous review articles have evaluated nutraceuticals [1,2,3,4]. Regarding skin, several reviews have addressed various aspects of skin health, focusing on a limited selection or special groups of nutraceuticals [5,6,7,8], particular aspects of skin health [9,10,11,12,13,14] or nutribiotics for skin care [15]. A recent review article demonstrates a clear connection between diet and skin health and provides recommendations for the use of certain key nutrients [16]. However, there has not yet been a comprehensive evaluation of commercially available nutraceuticals marketed for skin health in terms of their clinically proven efficacy.
This article aims to provide a comprehensive overview of the current state of science and research regarding the demonstrated effects of nutraceuticals on skin health. The main objective of this review is to classify a broad range of commercially available nutraceuticals based on the availability and quality of published efficacy data. Health claims for nutrients are regulated in the EU by the European Food Safety Authority (EFSA). The EU Regulation 1924/2006 on nutrition and health claims on foods, commonly referred to as the Health Claims for Food Regulation, establishes uniform requirements across Europe for the use of such claims [17]. Nutritional claims describe specific nutritional properties of foods, such as their energy content or their content of nutrients or other substances. Health-related claims establish a connection between nutrients in a product and health benefits. They are strictly regulated and apply only to the nutrients contained in the nutraceuticals. Usually, health claims refer to the influence on structures and functions of the body.
In contrast, beauty claims relate to the appearance of the body [18], such as skin appearance. Beauty claims also require scientifically substantiated justification. However, they are not subject to EFSA review, as beauty claims cannot, by definition, be health claims at the same time. Scientific evidence of efficacy is nonetheless essential for beauty claims as well. To provide greater clarity regarding the skin effects of nutraceuticals, common nutraceuticals have been assessed for their suitability in influencing skin health based on the available studies and taking into account the evidence and relevance of data.
Due to the complexity of the topic, the wide range of nutraceuticals, and the great range of informative value of the existing studies, the subjective assessments of the authors play a decisive role in the classification of the substances. Therefore, this review can only be narrative in nature, although efforts were made to incorporate as many aspects of a systematic or scoping review as possible.

1.1. Nutraceuticals

The strict distinction that previously existed between the pharmaceutical and food markets is becoming more and more blurred. A health-conscious approach to one’s own body has become commonplace, manifesting itself across all areas of life. Today, the focus extends to whether a food is beneficial or detrimental to health and to what extent foods can provide a physiologically active additional benefit. This trend is not entirely new: as early as the time of Hippocrates, the preventive value of nutrition for human health was recognized—yet he clearly distinguished between nutrition and medicine. This distinction remains relevant today: while nutrition is not a form of therapy, it constitutes an essential foundation for maintaining and promoting health.
To date, there is no clear regulatory definition for nutraceuticals (Table 1). The term “nutraceuticals” is a syncretic neologism derived from the English words “nutrition” and “pharmaceuticals”. It was coined by the American physician Stephen De Felice, founder of the Foundation for Innovation in Medicine [19]. He used this term to describe foods or components of foods that provide a medical or health benefit, including the prevention and treatment of diseases. In contrast to pharmaceuticals, nutraceuticals are typically not synthetic substances developed for the treatment of specific conditions. They primarily contain nutrients and natural compounds that can be consumed as food or food ingredients. Unlike many pharmaceuticals, they are not xenobiotics and, thus, are generally well-tolerated, harmless, and safe even when used long-term.
Although there is often no clear distinction between nutraceuticals and other food categories, such as dietary supplements, foods for special medical purposes, functional foods, and novel foods, there has been considerable change in the literature over the last five years. Modern definitions define separate categories: “Nutraceuticals” are concentrated bioactive products that are typically offered as tablets, capsules, powders, or ampoules and are often used for therapeutic or preventive purposes. In contrast, the term “functional foods” refers to whole foods or food products that offer health benefits beyond basic nutrition when consumed as part of a normal diet. Distinct definitions can also be found for dietary supplements and nutraceuticals: Dietary supplements are intended to supplement a deficiency (vitamins and minerals), but nutraceuticals go beyond that, imparting a therapeutic effect.
Nevertheless, the Dietary Supplement Health and Education Act (DSHEA) does not differentiate between nutraceuticals and dietary supplements. They are defined as products that contain isolated, sometimes chemically pure food ingredients in high dosages, provided in non-conventional food formats, and attributed with special health effects. They support nutrition and contain one or more of the following ingredients: vitamins, minerals, herbs, plant extracts, amino acids, or nutrients [20].
Table 1. Definitions for “Nutraceuticals” (According to Santini et al. 2018 [21]).
Table 1. Definitions for “Nutraceuticals” (According to Santini et al. 2018 [21]).
SourceNutraceuticals Are…
DeFelice, 1995 [19]
food or nutrient that provide medical or health benefits, including the prevention and treatment of diseases.
Zeisel, 1999; DSHEA [22]
dietary supplements that deliver a concentrated form of nutrients and natural active ingredients in food in a non-food-like manner to improve health.
Brower, 1998 [23]
all kinds of food or nutrients that have medical and health benefits and are suitable for prevention and therapy, among other things.
Merriam-Webster Dictionary, 2015 [24]
food as fortified food or dietary supplements that have a health value in addition to their nutritional value.
European Nutraceutical Association (ENA), 2016 [25]
dietary products that have health or medical effects that can be used, among other things, for prevention and therapy.
Nutraceuticals are also referred to as “food supplements”, “functional foods”, “superfoods”, “whole foods”, or “health foods”. The EFSA categorizes these products as “food”, “food ingredients”, “foods for specific groups”, “foods for specific medical purposes”, “dietetic products”, “traditional food”, “novel food”, or “novel food ingredients”.
This document focuses exclusively on foodstuffs (including food ingredients such as nutrients and natural agents), encompassing dietary supplements but excluding medical devices and pharmaceuticals. Nutraceuticals encompass a vast array of plant and animal-derived nutrients, vitamins, and minerals. In various reviews, authors have attempted to classify and functionally categorize nutraceuticals [1,2], some of which have served as a basis for the development of this overview article.

1.2. Target Audience and Market

The target audience for these nutraceuticals comprises physically healthy individuals seeking to enhance their skin appearance and maintain skin health. The concept of “beauty from within” has gained widespread acceptance, supported by scientific evidence demonstrating nutrition’s lasting impact on skin health [26]. Furthermore, the increasing life expectancy has led to growing demands for maintaining a youthful appearance. According to Global Industry Analysts’ market analysis, the global nutraceuticals market is projected to reach USD 441.7 trillion by 2026, with an average annual growth rate of 7.8% (source: www.prnewswire.com/news-releases/global-nutraceuticals-market-to-reach-441-7-billion-by-2026--301491307.html (accessed on 27 March 2022). Currently, the European market is the largest for nutraceuticals, followed by Asia and North America, with the Asian market experiencing the strongest growth.

1.3. Skin Physiology

The skin, functioning as a boundary organ, provides multiple protective barriers—physical, chemical, biological, and immunological against environmental factors. These barriers protect against external influences such as temperature extremes (heat and cold), environmental conditions (humidity, wind), physical contaminants (dust, dirt), dehydration, UV radiation, harmful substances, pathogens, and much more. In response to excessive UV exposure, the skin develops protective mechanisms like a thickening of the stratum corneum (“light callus”) and an increase in melanin production, leading to skin pigmentation (tanning).
The skin contributes to thermoregulation through multiple mechanisms: Releasing of excess heat through convection and evaporation of sweat and water, constricting blood vessels, and causing piloerection (commonly known as “goosebumps”) to maintain a constant body temperature in cold conditions. Notably, the stratum corneum (horny layer), being the outermost layer of the skin, and underlying epidermal layers undergo continuous renewal as a defensive mechanism against external influences. In the stratum basale, new cells are constantly generated, migrating upwards, keratinizing (transformation of keratinocytes into resistant corneocytes), and then undergoing programmed cell death.
The skin’s intrinsic barrier function provides protection against pathogens (bacteria, viruses, fungi) as well as mechanical stress and irritative or allergenic substances, including fine particulate matter. In humans, this barrier consists of a multilayered, partially overlapping squamous epithelium (corneocytes) with a precisely organized intercellular lipid matrix composed of cholesterol, free fatty acids, and ceramides. Additionally, the stratum corneum contains water-binding substances (natural moisturizing factor) and sebaceous lipids on the surface. The acidic pH in the upper stratum corneum reduces colonization by pathogenic viruses and bacteria [27,28].
Furthermore, the epidermis contains nerve fibers that extend just below the stratum corneum, as well as inflammatory and immune cells. Beneath the epidermis lies the dermis, a highly elastic and tensile tissue extending into the subcutaneous fat tissue. It primarily consists of cellular elements (connective tissue cells, fibroblasts, and fibrocytes), along with structural elements (dermal fibers, collagen, elastin), all embedded in a gel-like ground substance known as the extracellular matrix. The dermis houses neural components (nerve fibers, tactile sensory cells, cold receptors), vascular elements (blood and lymphatic vessels), and appendages (hair follicles with smooth muscle fibers, sweat, and sebaceous glands). The dermal vasculature serves dual functions: Nutrient supply to the epidermis and significant contribution to the macroscopic skin appearance through moisturizing factors (e.g., hyaluronic acid) affecting skin turgor. During the aging process, the degradation of elastin and collagen becomes apparent through a loss of elasticity and firmness at the skin’s surface.
The subcutis serves as a reservoir for heat and nutrients, cushioning underlying structures, dampening external pressure and impacts, and providing protection against heat loss. Recent findings suggest that subcutaneous adipose tissue also has additional functions, such as hormone production. Age-related loss or redistribution of subcutaneous fat is an important aspect of the appearance of older individuals.

1.4. Skin Health

Healthy skin significantly contributes to a person’s attractiveness. The more uniform the pigmentation and the smoother the surface topography, the more appealing a face appears [29]. Women with healthier skin are perceived as younger, an effect observed in both facial and body skin. Skin without visible abnormalities or lesions can appear up to five years younger. Skin health is a visible indicator of skin quality, characterized by four perceptual parameters: evenness of skin tone, evenness of the skin surface, skin firmness, and skin glow [30].
Skin health and quality are influenced by various factors. External, particularly chronic influences such as cold or heat, mechanical or chemical stress, mental strain, and environmental noxae like UV radiation or particulate pollution, can have a lasting impact on skin health. Additionally, age-related changes in skin function directly impact skin health. The progressive degradation of dermal components, specifically collagen and elastin, combined with decreased moisture retention due to reduced endogenous hyaluronic acid production, manifests as visibly diminished firmness and elasticity, leading to wrinkle formation [31,32]. Oxidative stress, characterized by an imbalance between free radicals and antioxidants, significantly contributes to skin aging through both epidermal and dermal damage [33].
With aging, transepidermal water loss (TEWL) as a marker of the “inside-outside” barrier is slightly reduced due to diminished blood circulation. However, the “outside-inside” barrier is compromised, primarily due to thinning of the skin, particularly the stratum corneum (the primary barrier location), and a slowed metabolism. These changes result in increased permeability and susceptibility to environmental irritants. Inflammatory skin diseases can disrupt both the “inside-outside” and “out-side-inside” skin barriers regardless of age.
The following outcome parameters were included in the literature-based review to evaluate improvements in one or more determinants of skin health:
  • Skin hydration;
  • Transepidermal water loss (TEWL);
  • Skin elasticity/firmness;
  • Wrinkle depth/wrinkle reduction;
  • Collagen synthesis/collagen content;
  • Skin roughness/surface smoothness;
  • Skin density/dermal thickness;
  • Skin appearance/subjective skin quality;
  • Reduction in UVB-induced damage/photoprotection;
  • Inflammatory markers/anti-inflammatory effects;
  • Skin lipid composition/ceramide levels;
  • Skin pigmentation/melanin content;
  • Healing and regeneration from skin diseases;
  • Oxidative stress markers;
  • Sebum secretion/skin surface lipid levels.
Individual nutrition represents another crucial factor affecting skin health. Nutritional deficiencies, whether resulting from malnutrition or restrictive dietary practices, can manifest as visible skin conditions. Intervention studies suggest that supplementation with certain nutrients such as specific amino acids, carotenoids, flavonoids, and vitamins (particularly vitamins A, C, D, and E) can support skin health, enhance skin quality, and potentially delay skin aging.
To evaluate the efficacy of selected nutraceuticals in maintaining, protecting, and promoting skin health, we have compiled and assessed relevant studies according to their evidence levels.

2. Materials and Methods

This overview examines selected common nutrients that are marketed either as nutraceuticals or as components of nutraceuticals, claiming positive effects on skin health. The analysis primarily focuses on products available in the German market as of September 2024, though many of these products are distributed internationally.
The examined nutraceuticals and nutrients were categorized into three groups: 1. Ingredients with proven in vivo efficacy according to Evidence Level I, 2. Ingredients with less well-established efficacy according to Evidence Level II, and 3. Ingredients with insufficiently documented effects corresponding to Evidence Level III. The results of this categorisation were summarised as tables, along with relevant study references and resulting evidence levels. When clear categorization proved challenging, decisions were based on both the quantity and quality of available review literature.
While this review encompasses literature through December 2024 and aims to include the majority of commercially available and scientifically documented substances, it does not claim to be exhaustive. Due to the continually increasing variety of nutraceuticals, the growing number of clinical studies, and new scientific insights into mechanisms of action, the evaluation of the evidence can only represent a snapshot in time. Consequently, the assessment of the evidence and the number of substances with established efficacy may change over time.

2.1. Search Strategy and Criteria for the Assessment of Nutraceuticals Affecting Skin Health

This review article classifies nutraceuticals according to their beneficial effects on skin health, with classifications guided by the quality of empirically gathered and assessed scientific evidence. Scientific validation of claimed benefits remains the critical factor in assessment, as emphasized by Kalra EK (2003) [34]: “Nutraceuticals still need support of extensive scientific study to prove their effects with reduced side effects”. The European Nutraceuticals Association (ENA) also bases its decisions on the level of scientific evidence for the nutraceuticals it presents (Table 1).
The assessment of evidence involved comprehensive literature research through PubMed (National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD, USA) and Google Scholar (Google LLC, Mountain View, CA, USA) databases (through December 2024), encompassing preclinical and clinical studies, all types of reviews, and meta-analyses. Only studies providing a statement on the efficacy of the respective nutraceutical were included in the analysis. The availability of high-quality positive clinical studies and reviews was considered the key criterion for a positive evaluation. In addition to the number of available studies, the quality of the studies was primarily decisive for the classification, in the following ascending order: Reviews → Meta-analyses → Preclinical studies → Randomized controlled trials (RCT) → Placebo-controlled double-blind trials (PCDB). Nutraceutical dosage was largely disregarded due to inconsistent or missing dosage information across the reviewed literature. The evaluation of evidence is based on the finding that, where assessable, the dosages used in the cited studies generally align with the recommended intake ranges for the respective products despite some degree of variation.

2.2. Classification of Evidence

The most commonly used classification of evidence follows the recommendations of the Agency for Healthcare Research and Quality (AHRQ), which has gained worldwide recognition and has been the basis for other guidelines (e.g., S3 guideline for the diagnosis and therapy of bipolar disorders, 2012) and is partially modified and utilized by the Cochrane Collaboration (CC) and the German Cochrane Center [35,36]. Another example of a frequently employed classification of evidence is the international classification by CEBM, which is somewhat more detailed but does not differ significantly in its fundamental classification from the AHRQ classification [37].
However, the strict classification according to AHRQ did not appear sufficiently practicable for evaluating nutraceuticals in the context of this review. Since the evaluated substances and products are not pharmaceuticals or medical devices but solely OTC products (nutraceuticals) with “cosmetic” effects, the assessment was simplified (Table 2) in accordance with the guideline “Dermocosmetics against Skin Aging” of the German Society for Dermopharmacy (GD) [38].
Table 3, Table 4 and Table 5 provide an assessment of the evidence for all considered substances, as well as an overview of the available literature supporting the classifications. Furthermore, the tables indicate which substances are associated with health claims related to the skin. The evaluation of whether the effect of a substance is sufficiently substantiated is based on the following quality and quantity of the existing study literature:
Ingredients with clinically proven effects (Group 1): This category encompasses all ingredients of the selected nutraceuticals whose efficacy has been demonstrated through in vivo placebo-controlled double-blind studies (PCDB, Ia) or other randomized controlled studies (RCT, Ib) using objective methods (Table 3). A positive efficacy claim requires either a substance-specific study with positive outcomes or an RCT in a related application area or in combination with other substances, supported by comprehensive clinical data and efficacy indicators.
Ingredients with less well-documented efficacy (Group 2): This category comprises nutraceuticals or ingredients studied only in lower-significance trials (lacking RCT/PCDB methodology), with limited research data, or without substance-specific or product-specific studies. It also includes ingredients whose efficacy has been demonstrated only in vitro or in combination with other substances (Table 4).
Ingredients with insufficiently documented effects (Group 3): This category encompasses all other nutraceuticals whose efficacy has only been described or postulated in reviews or other publications (Table 5).

3. Results

3.1. Group 1: Active Ingredients with Clinically Proven Efficacy

3.1.1. Vitamins

  • Vitamin A
Refer to carotenoids: β-carotene, lutein, zeaxanthin, astaxanthin, lycopene.
  • Biotin (Vitamin B7 or Vitamin H)
Biotin supplements are used to maintain healthy skin and mucous membranes. Biotin deficiency can manifest in various symptoms across body systems. These include neurological symptoms such as depression, drowsiness, and hallucinations; sensory disturbances including muscle pain, hypersensitivity, and localized dysesthesia; digestive issues like loss of appetite and nausea; as well as dermatological changes including hair loss, changes in hair color, brittle nails, and skin alterations. The German Society for Nutrition (DGE) recommends a daily biotin intake of 5–60 µg [39]. Biotin is generally regarded as safe and well-tolerated. Being water-soluble, excess biotin is eliminated through the kidneys, making overdose virtually impossible.
Substance and mechanism of action: Biotin (Vitamin B7, Vitamin H), belonging to the B-complex group, serves as a vital component in the fundamental metabolic regulation of carbohydrates, proteins, and fats. As a prosthetic group for enzymes, it plays an important role in the epigenetic regulation of gene function.
Evidence base: The beneficial effects of biotin on skin health have been thoroughly documented in comprehensive reviews and demonstrated in preclinical studies. Most human studies are dated and mainly address the role of biotin in maintaining healthy hair and nails. Two significant EFSA Health Claims support its efficacy, stating that “Biotin contributes to the maintenance of normal skin” and “Biotin contributes to the maintenance of normal hair”. Numerous reviews, preclinical studies, and one PCDB study (in combination with silicon) have been found regarding biotin as a dietary supplement. Moreover, biotin supplements at higher dosages (5 mg and above) are approved as drugs for the treatment and prevention of biotin deficiency, which has been shown to cause skin problems. Considering all these aspects, the efficacy of biotin for maintaining skin health and its appendages can be regarded as established.
  • Vitamin C
Vitamin C is used in numerous nutraceuticals either as a sole ingredient or in various combinations with other vitamins, nutrients, or minerals. It is characterized by significant antioxidant effects and plays a crucial role in maintaining the skin’s collagen network. Vitamin C has low toxicity and, even at higher doses (>1 g/day), causes only minimal side effects (e.g., diarrhea, gastrointestinal discomfort). The DGE recommends a normal daily intake of 20–125 mg [39].
Substance and mechanism of action: Vitamin C (L-ascorbic acid) is a natural, water-soluble vitamin found in high concentrations in fruits and tea. Unlike most animals, humans must obtain it through diet as they cannot synthesize it. It functions as a free radical scavenger with antioxidant properties, thereby reducing UVB-induced oxidative stress. Among others, the vitamin is essential for connective tissue formation, participates in the hydroxylation of essential amino acids for collagen synthesis, and neutralizes free radicals in the body. Its biologically active form, L-ascorbic acid, serves as a co-factor in collagen synthesis and, according to the literature, promotes both intra- and extracellular collagen formation.
Evidence base: Vitamin C stands as one of the most extensively studied anti-aging agents, with undisputed efficacy demonstrated through multiple studies, including PCDB. The EFSA has acknowledged its benefits with a specific health claim related to skin health: “Vitamin C contributes to normal collagen formation for the normal function of the skin”. Research has particularly shown that its effects are significantly enhanced when combined with vitamin E.
  • Vitamin E
Vitamin E encompasses a group of tocopherols, tocotrienols, and tocosterols. Located in the lipophilic portion of cell membranes, it provides protection against UV-induced lipid peroxidation. It has been demonstrated that after oral intake, vitamin E is transported through the sebaceous glands and mechanically distributed across the skin surface, allowing it to exert antioxidant effects in the outermost cell layers.
Among the eight naturally occurring compounds categorized as vitamin E, α-tocopherol is most significant for humans, representing nearly 90% of vitamin E in the body. Vitamin E supplements are commonly available for addressing deficiencies and frequently appear in other nutraceutical formulations. The DGE recommends a daily intake ranging from 11 to 15 mg [3,39]. While well-tolerated at recommended dosages, extended use of high doses may occasionally result in gastrointestinal issues.
Substance and mechanism of action: Vitamin E (tocopherol), a fat-soluble vitamin found naturally in oils, cereal germ, and nuts, is present in all animal cell membranes. Vitamin E has antioxidant, lipid-lowering, and antithrombotic properties. It exhibits antioxidant, lipid-lowering, and antithrombotic properties, functioning as a free radical scavenger to protect cell membranes, lipids, DNA, and lipoproteins from oxidative damage.
Evidence base: The protective effect of vitamin E on skin health against UVB damage has been extensively documented in numerous reviews and demonstrated through various studies, primarily using topical applications but sometimes also including oral administration. PCDB studies, however, have typically been conducted in combination with vitamin C. To date, there is no specific health claim for vitamin E regarding its effect on the skin. Nevertheless, based on the totality of available data and its classification as a dermocosmetic, its skin-related efficacy as a nutraceutical is considered established and classified with evidence level Ib (Table 3).

3.1.2. Fatty Acids, Lipids

  • Omega-3 Fatty Acids (PUFA)
Omega-3 fatty acids are essential fatty acids that the body cannot synthesize independently and must be obtained through dietary sources. For healthy individuals, normal dietary intake typically meets daily requirements. According to DGE recommendations, omega-3 fatty acid α-linolenic acid should constitute 0.5% of total daily energy intake, which corresponds to approximately 80 g of total fat for men with an energy reference value of 9.8 megajoules (2300 kcal; PAL 1.4) [39]. Omega-3 fatty acids occur naturally in algae, plants, and fish, primarily as fatty acid esters or triglycerides. While plant sources predominantly contain α-linolenic acid, fatty fish such as eel, carp, and sardines, along with algae, are rich in docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). Users should be aware of potential side effects, including digestive disturbances, reduced platelet aggregation, extended bleeding time, and mild transaminase elevations. According to recent assessments by the Consumer Advice Centre of North Rhine-Westphalia regarding cardiovascular diseases and diabetes, healthy individuals do not require additional omega-3 fatty acid supplementation. Furthermore, they warn that high-dose omega-3 products may pose significant health risks and could potentially interact with medications.
Substance and mechanism of action: Omega-3 fatty acids are long-chain polyunsaturated fatty acids (PUFAs) essential for human nutrition. Common nutraceutical ingredients include docosahexaenoic acid, eicosapentaenoic acid, or linoleic acid. When derived from plants, these fatty acids serve multiple functions: they provide energy through metabolism, become incorporated into cell membranes, and act as precursors for series-3 prostaglandins. Their beneficial properties include triglyceride reduction, antiarrhythmic effects, anti-inflammatory action, blood pressure reduction, and endothelial protection. The scientific literature also documents their photoprotective properties, particularly in increasing UV-induced erythema threshold.
Evidence base: The positive influence of omega-3 fatty acids on skin health is well-supported across numerous reviews. While many studies exist examining various omega-3 fatty acids, they frequently investigate combinations rather than individual substances. One notable PCDB study utilized evening primrose oil, which primarily contains omega-6 fatty acids and, like fish oil, is attributed with positive effects on the skin. These studies typically focus on UV-damaged skin or individuals with skin conditions such as psoriasis. In cardiovascular diseases, on the other hand, according to a recent meta-analysis no positive effect of dietary supplementation with fish oil capsules could be demonstrated (Table 3).
  • Ceramides
Ceramides (sphingolipids) are essential components of lipid bilayers, acting as a permeability barrier in the stratum corneum of the skin. While present in nearly all organs and cell membranes, they are particularly concentrated in the skin and brain. Topically applied ceramides have been used for several years in medical skin care and for the prevention of skin diseases such as atopic dermatitis and psoriasis. Their oral application as nutraceuticals is relatively new but is now being offered for the treatment of dry skin and aging skin. While no general dosage recommendations exist, common supplements provide 350 mg for once-daily intake, with no reported side effects to date.
Substance and mechanism of action: Ceramides, belonging to the sphingolipid family, are predominantly found in the skin, where they form specific structures, and also occur in the brain and other organs. Through coupling with various saccharides or phosphorylcholine, they serve as basic modules of glycosphingolipids and sphingomyelin. As central molecules in sphingolipid metabolism, signaling ceramides influence various processes, including cell growth inhibition, apoptosis induction, cell differentiation promotion, and inflammatory reactions. Structural ceramides work together with cholesterol and free fatty acids to form double lipid layers in the stratum corneum between corneocytes due to their amphiphilic structure. This creates a natural barrier that prevents both moisture loss and foreign substance penetration. Any disruption of the balance of these substances may result in dry skin or pathological skin conditions [84].
Evidence base: The efficacy of oral ceramides for skin health and especially the epidermal barrier function has been investigated through numerous preclinical and clinical studies. While in vitro research has demonstrated anti-inflammatory effects, PCDB studies have shown improvements in skin hydration, TEWL, age-related skin symptoms, and atopic dermatitis. In particular, studies showing positive effects on skin hydration and TEWL provide strong evidence for their role in supporting skin health.

3.1.3. Collagen

  • Collagen Peptides
Collagen is the most important extracellular structural protein in ligaments, tendons, and cartilage, as well as in muscle fascia. In young and healthy skin, it comprises nearly 80% of the composition, forming a vital scaffold in the dermis, the middle layer of the skin, that provides strength and structure, thereby significantly influencing skin appearance. Nutraceutical formulations typically use enzymatically hydrolyzed collagen peptides, whose characteristics vary considerably depending on the hydrolysis parameters and collagen source [106,107]. These variations can be unequivocally determined using nanoLC-MS/MS measurements. The collagen peptides used in nutraceuticals are primarily sourced from bovine or porcine sources or are derived from chickens or marine animals (e.g., fish, jellyfish, or sponges) [108]. While no general dosage recommendations exist for collagen peptide nutraceuticals, studies indicate an optimal intake of 2.5 g per day, with higher doses of 5 g showing no statistically significant additional benefits. Specific side effects related to the substance are hardly known. Allergic reactions to collagen hydrolysates have not been documented so far, likely due to collagen being a highly conserved structural protein with almost 100% similarity across organisms from jellyfish to humans [109]. A 2019 review by Choi et al. confirmed that collagen supplementation is generally safe with no reported adverse effects [93].
Due to the heterogeneity of collagen peptides, consumers should prioritize products for which product-specific, ideally placebo-controlled studies have been conducted, demonstrating a specific benefit of the product itself for skin physiology.
Substance and mechanism of action: Collagen peptides are enzymatically obtained through hydrolysis of native collagen. Following oral intake, they undergo further enzymatic breakdown in the gastrointestinal tract through existing enzymes (e.g., pepsin, pancreatin) [110,153]. While natural digestion results in molecular weight-dependent fragmentation, remarkably, up to 16% of hydrolyzed collagen with a molecular weight of 2.9 kDa is absorbed undigested through the intestinal wall [111]. Industrial enzymatic proteolysis typically yields fragments of 16–26 amino acids in length. However, absorption is highest only up to tetrapeptides, indicating that body-specific proteases must assist in the breakdown of collagen fragments. The absorption of collagen protein fragments likely involves active transport. Overall, the exact transport pathway of collagen peptides across the intestinal wall has not yet been conclusively and in detail clarified [115,129].
The structural collagen fibers are formed as a triple helix from individual procollagen strands, which are typically sufficiently available between the cells of the deeper skin layers [94,95]. When transported via the bloodstream to these deeper skin layers, collagen peptides may stimulate fibroblasts to produce body-specific components of the extracellular matrix, including collagen, hyaluronic acid, and elastin. These processes result in structural changes within the dermis, leading to improved skin physiology and reduced wrinkle formation in aging skin [113,130,131]. A particularly notable finding is that collagen peptides closely matching human collagen, designated as [HC] peptides, demonstrate especially high effectiveness [106,141,142]. The mechanism of action has been explored in several studies but is only partially understood so far [112,117,129,132,133].
Evidence base and source-dependent differences:
Bovine and porcine peptides: Numerous clinical studies worldwide have consistently demonstrated the positive effects of nutraceuticals containing collagen peptides on skin elasticity, hydration, density, and roughness, thereby improving overall skin health. Research has established now that collagen peptide supplementation effectively counteracts UV-induced skin damage [105]. Most of these studies have focused on collagen peptides sourced from bovine or porcine origins (Table 3). EU regulations require BOV (Bovine Spongiform Encephalopathy, BSE) risk controls and traceable sourcing; porcine collagen is non-halal, and bovine is only halal if certified. Use in cosmetics may be restricted in halal markets or countries with strict animal-origin regulations.
Marine collagen peptides are broadly accepted and highly bioavailable, with favorable regulatory status and halal suitability. Human PCDB studies consistently confirm benefits for skin elasticity and hydration.
Chicken collagen peptides are clinically supported for dermal effects (PCDB studies with extracts are available) but are less common in cosmetics. Regulatory acceptance depends on hygienic processing; halal status requires certified sourcing.
Plant-based alternatives to collagen peptides primarily include so-called collagen boosters, which are designed to stimulate the body’s own collagen production through certain nutrients or plant extracts, as well as synthetically produced collagen-mimetic peptides obtained through microbial fermentation. These alternatives do not contain real collagen. Evidence of their effectiveness for the skin is already available—a PCDB study has been identified—but is still limited and less conclusive compared to the data available for animal-derived collagen peptides.
Additionally, numerous positive study results exist for nutraceuticals that combine collagen peptides with other substances such as vitamins, minerals, plant extracts, and hyaluronic acid. The studies suggest that these active ingredients work synergistically, enhancing the overall effect. For one combination product, scanning electron microscopy, combined with the suction blister method for the first time, revealed visible improvements in collagen structure after several weeks of application [123] (Table 6).

3.1.4. Secondary Metabolites

  • Carotenoids: Β-Carotene, Lutein, Zeaxanthin, Astaxanthin, Lycopene
Carotenoids represent a group of secondary plant metabolites that, while not essential for humans, are considered beneficial to health. They naturally occur in bacteria, plants (particularly fruits and vegetables), and certain fungi. Currently, no established daily dosage recommendations exist for carotenoids, as appropriate dosing depends on various factors, including the specific indication. While therapeutic doses may reach up to 180 mg/day without causing adverse effects or hypervitaminosis A, the EFSA considers a maintenance dose of β-carotene of up to 15 mg/day to be safe.
Of the approximately 50 known carotenoids, a subset exhibits provitamin A activity, meaning they can be converted into vitamin A in the body, with β-carotene having the highest activity. Consequently, β-carotene is the most important precursor of vitamin A in foods. Vitamin A is used therapeutically to address deficiency, inadequate intake, and skin disorders. Manufacturers claim that nutraceuticals containing vitamin A promote healthier skin, strengthen the immune system, and improve vision. According to EFSA, the following health claim is permitted: “Vitamin A contributes to the maintenance of normal skin”. However, evidence of efficacy regarding skin health has primarily been demonstrated for topical formulations and for the precursor β-carotene. Vitamin A supplements, taken at the dosage recommended by the DGE [39] (approximately 1 mg/day), are well-tolerated but must not be taken in excess, as higher doses can be teratogenic.
Substance and mechanism of action: Carotenoids form an extensive class comprising over 600 fat-soluble plant pigments, all sharing a tetraterpenoid scaffold. Lycopene, the central compound in carotenoid biosynthesis, is believed to reduce collagen degradation in the skin and improve skin roughness. Through processes of cyclization, hydroxylation, and other functionalizations, lycopene serves as a precursor for all other carotenoids. β-carotene, the most well-known carotenoid, is used in the prevention and treatment of vitamin A deficiency, as a dietary supplement, in the management of erythropoietic protoporphyria, for pigment disorders, and in preventing “sun allergy”. Other carotenoids include lutein and zeaxanthin, regarded as nutrients beneficial not only for the eyes (e.g., in age-related macular degeneration) but also for the skin. They are natural components of the dermis and epidermis. Particularly, lutein is believed to protect the skin from harmful light exposure, enhance skin moisture, improve elasticity, and support the dermis and epidermis against oxidative stress.
Vitamin A (retinol) is a fat-soluble vitamin with numerous physiological properties, found only in animal products and occurring primarily in ester form in the subcutaneous layer. Retinol is considered to act both as a prohormone and a prehormone. It is present in plant foods as carotenoid precursor. Its biologically active form is all-trans-retinoic acid (tretinoin, Retin A, vitamin A acid). Since all-trans-retinoic acid is a prescription medication not permitted in nutraceuticals, it will not be discussed in detail here. In non-pharmaceutical products, only less potent forms of vitamin A may be used, such as free retinol, retinyl palmitate, retinyl acetate, and retinaldehyde. These compounds are converted into the biologically active all-trans-retinoic acid in the skin.
To meet vitamin A requirements, humans can utilize not only retinol and retinyl esters but also provitamin A (β-carotene). The activity of dietary carotenoids as provitamin A is expressed in terms of retinol equivalents, where approximately 6 mg of β-carotene and 12 mg of other provitamin A carotenoids correspond to 1 mg of retinol equivalent.
In the human body, six carotenoids play a vital role: β-carotene, α-carotene, lycopene, β-cryptoxanthin, lutein, and zeaxanthin. Most of these function as antioxidants. Carotenoids, particularly lycopene (e.g., in tomatoes), are regarded as efficient scavengers of the highly reactive singlet oxygen.
Vitamin A is one of the skin’s natural antioxidants. In a study involving cultured human skin fibroblasts, it was demonstrated that retinol induces the expression of the elastin gene and the formation of elastic fibers. This effect is based on the activation of nuclear receptors that bind to DNA and trigger transcription and gene expression of specific genes. RAR and RXR receptors are the two primary receptor families activated by vitamin A. They are transcription factors that activate the expression of specific genes.
Evidence base: β-Carotene is a precursor of vitamin A, which has undeniable effects on skin health. The EFSA has approved the health claim: “Vitamin A contributes to the maintenance of normal skin”. Positive influences on relevant skin parameters or UV protection functions have been demonstrated for several carotenoids in PCDB studies, including β-carotene, zeaxanthin, and astaxanthin. Regarding lycopene, most studies are less convincing. Nevertheless, this substance can also be classified as effective, not least because of numerous review mentions and a PCDB study (Table 3).
Topical application of all-trans-retinoic acid has been shown to improve the overall appearance of the skin, fine and moderate wrinkles, skin roughness, pigmentation, and skin elasticity. Although direct studies on vitamin A supplements for skin health are lacking, research has shown that β-carotene, as a precursor of the vitamin, can provide UV protection and that nutraceuticals can substitute for vitamin A in cases of deficiency (Table 3).
Other carotenoids, such as astaxanthin, have also demonstrated positive effects on the skin, contributing to a favorable evidence assessment. While this evidence is promising, more research is needed to fully understand the effects of oral vitamin A and carotenoid supplements on skin health.

3.1.5. Plant and Animal Substances/Extracts

  • Polyphenols: Pine Extract (Maritime Pine Bark Extract), Flavonoids, Resveratrol
Pine extract, derived from the bark of the French maritime pine (Pinus pinaster subsp. atlantica), is available in standardized form, e.g., as Pycnogenol®. The extract contains polyphenols and is used in dietary supplements (100–500 mg/day) for photoprotection against UV-induced skin damage, as well as in cosmetics. Products containing pine extract are marketed for achieving significant improvements in skin hydration and elasticity. Side effects are rare, with mild digestive issues reported in 2.4% of study participants (“Pine Bark Extract Pycnogenol®—vitamine-ratgeber.com”, available online: https://vitamine-ratgeber.com/weitere-vitalstoffe/pinienrindenextrakt-pycnogenol/ (accessed on 27 March 2025)).
Other notable polyphenols include catechins in green tea (see Section 3.2.3.), resveratrol (found in red grapes and wine and marketed as a dietary supplement due to its antioxidant properties), and flavonoids (present in cocoa).
Substance and mechanism of action: Maritime pine extract consists of 65–75% procyanidins, which are biopolymers composed of catechin and epicatechin units. These units are converted by the human gut microbiota into postbiotic active metabolites. The extract also contains antioxidant plant acids and bioflavonoids.
Green tea, an unfermented form of black tea, contains polyphenolic compounds such as epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC), and epigallocatechin gallate (EGCG). Resveratrol belongs to the group of phytoalexins. The polyphenols found in cocoa are primarily flavonoids.
Polyphenols, which are also found in black tea, act as potent antioxidants by stimulating the synthesis of antioxidant enzymes and binding to free radicals. Additionally, polyphenol-rich extracts inhibit the onset and progression of chronic inflammatory diseases by significantly reducing the activity of NF-κB. They also decrease the release of specific transcription factors, which leads to a reduction in the release of other inflammatory molecules, such as interleukins, prostaglandins, CRP, TNF-alpha, and COX.
Evidence base: Numerous clinical studies have investigated the effects of pine extract (e.g., Pycnogenol®) on skin health and appearance, although most of these studies used combination products or topical applications. Based on objective study results and a variety of supporting publications, the evidence for its effectiveness can be deemed sufficient.
In vitro, resveratrol has been shown to inhibit inflammatory cells and extend the lifespan of mice. Although clinical evidence for its influence on skin health currently exists only for combinations of resveratrol with other nutrients (e.g., pomegranate fruit extract), many other objective studies allow for a conclusion of effectiveness. A long-term study of the flavanols in concentrated cocoa demonstrated their positive effects on skin blood flow and skin quality (Table 3).
  • Aloe Vera Gel
The gel obtained from the inner leaf of the aloe vera plant is primarily known for topical use in skin care, as well as its application to wounds and sunburned skin. Less commonly recognized is its oral use as a nutraceutical for supporting skin health and pigmentation. Anthraquinone-free aloe gel is available as a novel dietary supplement and does not require medicinal approval. While general dosage recommendations are not yet established, commercially available gels or juices are typically recommended at a dose of 20–50 mL per day. Significant side effects have been reported only for anthraquinone-containing juices (see below) and topical preparations (burning sensation, allergic dermatitis, itching).
Substance and mechanism of action: Aloe vera gel is derived from the water-storing tissue of the leaves and contains a variety of active components, including polysaccharides, vitamins, minerals, essential oils, and phytosterols (such as cycloartenol and lophenol). Aloe leaves must always be peeled, as the unpeeled leaves contain anthraquinones, classified as “not safe” by the Federal Institute for Risk Assessment (BfR) and the EFSA due to severe side effects. Aloe vera gel and juice are attributed with antimicrobial, antioxidant, antiproliferative, anti-inflammatory, moisturizing, and anti-itch properties.
Evidence base: Based on the available in vitro and in vivo (PCDB) studies, the positive impact of aloe vera gel on skin health can now be regarded as established. However, further randomized controlled clinical trials are needed to provide more specific insights into the effectiveness and safety of the gel or juice (Table 3).
  • Sea Buckthorn Oil
Sea buckthorn berries are renowned for their high vitamin content, particularly in the treatment of cold illnesses and febrile infections. Sea buckthorn oil is used topically for skin care and is also claimed to support gut and heart health, as well as wound healing, when taken orally.
Substance and mechanism of action: Sea buckthorn oil, derived from the seeds, contains vitamin E, beta-carotene, and various omega-fatty acids, all of which have been shown to have positive effects on skin health (see above).
Evidence base: A PCDB study demonstrated positive skin effects from a mixture of sea buckthorn fruit and seed oil (Omegia® Softgel). Given the positive results from other studies and the supportive evidence for the individual components, the efficacy of sea buckthorn oil for skin health can now be considered well-established (Table 3).
Other Extracts: Polypodium leucotomos, pomegranate, blueberry extract, licorice root extract.
The fern Polypodium leucotomos, originally native to Central America, was used by the Maya as a “blood purification tea”. It is now cultivated on plantations in various countries across Latin and South America. The fruit of the pomegranate (Punica granatum), widespread in Asia and the Mediterranean, is utilized in various food applications. Extracts from both plants are commonly included in cosmetics due to their reputed skin care benefits.
Blueberry extracts are used for the symptomatic treatment of mild diarrhea, relief from a feeling of heaviness in the legs due to mild venous circulation disorders, and to support eye and heart health. While their use for skin health is primarily known as additives in cosmetics, some nutraceutical products also claim positive effects on the skin.
Licorice root extract, sweet and aromatic with a hint of licorice, is mainly known for treating inflammation, gastrointestinal complaints, and infections in the oral and throat areas. However, its use for skin improvement, particularly for skin lightening, is gaining increasing attention.
Substance and mechanism of action: The extract from Polypodium leucotomos contains various bioactive substances, including phenolic acids and flavonoids, which have antioxidant effects and contribute to protecting the skin from UV damage. Glycosylated flavonoids are thought to have anti-inflammatory properties and help neutralize free radicals. Triterpenes are known for their anti-inflammatory and antimicrobial properties. Polysaccharides (see below) are credited with supporting the immune system and exhibiting anti-inflammatory properties. Additionally, proteins and amino acids in the extract may help maintain skin structure and support regeneration.
Pomegranate extract also contains several skin-relevant substances, including polyphenols and flavonoids (mentioned previously), vitamin C, punicic acid, phytoestrogens, and phytosterols, all of which are believed to have skin-protective effects. Blueberry extracts contain similar substances, such as flavonoids, terpenoids, and anthocyanins. Licorice root extract also contains flavonoids and terpenoids, along with coumarin.
Evidence base: Positive effects of Polypodium leucotomos and Punica granatum on the skin have been described in several reviews. Clinical RCT evidence, including PCDB studies, supports these effects, leading to a positive evaluation of the evidence situation. Similar findings apply to blueberry extract, for which a recent PCDB study showed positive effects on skin aging and complexion. Several clinical studies on licorice root extract were identified, but mainly involving combination products (Table 3).
  • Hyaluronic Acid
Hyaluronic acid, found throughout the human body, is present in large amounts primarily in the skin, bones, intervertebral disks, joint fluid, and vitreous body of the eye. Its use in anti-aging cosmetics is based on the observation that the body’s production of hyaluronic acid decreases with age. Consequently, hyaluronic acid has become a key ingredient in numerous dermocosmetics and is widely used for wrinkle filling. Recent studies have shown that the intake of nutraceuticals containing hyaluronic acid can improve skin moisture levels and elasticity, as well as reduce wrinkles. There have been no known side effects associated with the intake of hyaluronic acid (in capsule form) at the recommended dosages (100–200 mg per day).
Substance and mechanism of action: Hyaluronic acid is a long-chain, linear polysaccharide that serves as a key component of the extracellular matrix in the connective tissue of the skin. Due to its unique chemical properties, hyaluronic acid plays multiple mechanical roles in connective tissue. Its ability to bind large quantities of water relative to its mass ensures sufficient skin moisture, skin firmness, and resistance to pressure.
Evidence base: While efficacy has been well-demonstrated for topical application, especially for short- to medium-chain hyaluronic acid fragments in supporting skin health, recent studies have shown such effects with the oral intake of longer-chain hyaluronic acid molecules as well (Table 3). Despite some weak effects and critical evaluations, the efficacy can generally be regarded as established.

3.2. Group 2: Active Ingredients with Less Well-Documented Effectiveness

3.2.1. Minerals and Trace Elements

  • Zinc
Zinc is an essential trace element that cannot be synthesized by the body. Zinc deficiency, resulting from malnutrition or hereditary zinc deficiency syndromes, may manifest as impaired linear growth, skin eczema, diarrhea, and wound healing disorders.
Substance and mechanism of action: As a component of numerous enzymes and proteins, zinc plays a key role in numerous biochemical reactions in the body, including those related to skin health. It acts as an important cofactor for cellular activity and helps protect cells from lipid peroxidation, UV-induced cytotoxicity, and oxidative stress. In the skin, zinc is primarily found in the epidermis, where it is essential for epidermal proliferation and keratinocyte differentiation. Excessive zinc intake, particularly when copper intake is low, can impair copper absorption, potentially leading to anemia.
Evidence base: There is substantial evidence supporting the benefits of zinc for skin health, and the EFSA has published a health claim stating that “zinc contributes to the maintenance of normal skin, hair, and nails”. However, RCTs specifically focused on skin health are still lacking. One earlier study found no skin-improving effects (Table 4).
  • Manganese
Manganese is a trace element important for bones, connective tissue, and metabolism. Symptoms of manganese deficiency (which is rare) may include an increased risk of infections, poor wound healing, dry skin, and graying hair. According to the DEG, children older than 7 years, adolescents, and adults require approximately 2 to 5 mg of manganese daily. Currently, there is no evidence suggesting that a manganese-rich diet, such as a plant-based one, is associated with adverse side effects. However, excessive manganese intake can lead to neurotoxic and motor disturbances.
Substance and mechanism of action: Manganese is an essential trace element that can be toxic at high doses and is a component of various enzymes. Intracellularly, manganese is mainly localized in the mitochondria, where it acts as an activator of specific enzyme systems. Manganese is also present in lysosomes and the nucleus. It acts as an activator for numerous enzymes involved in gluconeogenesis and collagen synthesis. In particular, it is important for antioxidant metabolism as a component of superoxide dismutase in the removal of oxygen radicals.
Evidence base: Despite numerous references in the literature, evidence for the role of manganese as a skin-affecting nutraceutical is limited. Regarding connective tissue, the EFSA has a health claim stating that “manganese contributes to normal connective tissue formation”. In a PCDB study, a melon extract was used for supplementation instead of manganese supplementation. However, since the extract indirectly provided manganese through its manganese-dependent superoxide dismutase content, it is possible to infer—at least to some extent—the effect of manganese intake on skin health (Table 4). Nonetheless, as with zinc, the evidence remains insufficient.

3.2.2. Amino Acids

  • L-Arginine, L-Glutamine, L-Leucine, etc.
Amino acids are fundamental for human nutrition. A balanced diet typically ensures an adequate intake of essential amino acids through animal proteins or a well-combined mix of plant proteins. Cosmetics and nutraceuticals containing various essential and semi-essential amino acids are widely marketed in the beauty industry to maintain healthy, youthful-looking skin. Products featuring cysteine, arginine, creatine, glutamine, leucine, glycine, (hydroxy)proline, or lysine are common. The WHO recommends daily intakes ranging from 4 mg/kg body weight (e.g., cysteine) to ≥30 mg/kg body weight (e.g., lysine, leucine). However, the dosages of commercially available products, particularly for individuals with low body weight, often exceed these recommendations.
Substance and mechanism of action: The essential amino acids for humans include isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine. Arginine and histidine are semi-essential, as they need to be consumed during specific life stages (growth, regeneration). Proteinogenic amino acids are the building blocks for body peptides and proteins, while non-proteinogenic amino acids serve as enzymes, hormones, or neurotransmitters. Over twenty proteinogenic amino acids are currently known, and as fundamental components of collagen peptides, they are indispensable nutrients for skin integrity.
Evidence base: Although the essential role of many amino acids in skin health is undisputed, there are only a few studies demonstrating the effects of individual amino acid supplementation on skin health, and substance-specific RCTs are still lacking (Table 4).

3.2.3. Secondary Natural Substances

  • Polyphenols: Catechins from Green Tea Extract, Grape Seed/Skin Extract
Polyphenols, including catechins found in green tea, are among the key constituents, along with caffeine. Grape seed extract is attributed with several health-promoting effects, including positive impacts on circulation, cardiovascular health, and wound healing. Similar benefits are associated with grape skin extract, which focuses on vascular health and protection against oxidative stress.
Substance and mechanism of action: The mechanisms of action of polyphenols have been briefly mentioned (see above).
Grape seed extract primarily contains phenolic compounds like catechins, proanthocyanidins, and flavonols, while grape skin extract mainly comprises polyphenols like oligomeric proanthocyanidin complexes (OPCs) and anthocyanins.
Evidence base: Animal studies and a few observational studies have shown that polyphenols from green tea significantly protect against UV-induced skin damage and immunosuppression following topical and oral administration. Despite one study with a negative result, they appear promising but need confirmation through clinical trials. No substance-specific RCTs for grape seed/skin extract have been found, and there is only limited evidence from combination products. Therefore, robust evidence for the efficacy of these polyphenols remains lacking (Table 4).

3.2.4. Plant and Animal Substances/Extracts

  • Citrus/Rosemary Extracts
Citrus and rosemary extracts are commonly used as food additives for preservation. As nutraceuticals, they are often combined with various other nutrients like vitamins or minerals. Pure extracts, such as blood orange extract, are also marketed for various therapeutic purposes. No side effects have been reported in connection with such extracts. The known interactions between grapefruit consumption and certain medications are attributed to the presence of furanocoumarins, which are not found in citrus extracts.
Substance and mechanism of action: Extracts from various citrus plants typically contain high levels of vitamin C, essential oils, flavonoids, and minerals. Rosemary extract mainly consists of essential oils (terpenes, carnosol, carnosic acid) and flavonoids. These extracts are considered relatively potent antioxidants, making them suitable for use in skin health disorders.
Evidence base: Evidence for the effectiveness of citrus and rosemary extracts is still insufficient. Although several studies exist regarding their impact on skin health, most clinical trials, including PCDB studies, have been conducted with combinations of multiple substances or extracts, typically combining citrus extract with rosemary extract (Table 4).
  • Acerola Extract
Acerola is the drupe of a Malpighia species. While it resembles the native cherry in appearance, it is not related to it.
Substance and mechanism of action: Acerola is one of the richest natural sources of vitamin C. The fruit and its extract also contain provitamin A, vitamins B1, and niacin, as well as minerals like iron, phosphorus, and calcium. The effects of vitamins on the skin are described in Section 3.1.1 and Section 3.3.1.
Evidence base: Currently, there are no PCDB studies available, and most research has investigated combinations with other substances. Due to the low level of evidence, a definitive demonstration of efficacy regarding skin health cannot yet be considered established (Table 4).

3.2.5. Probiotics and Prebiotics

  • Probiotics (Lactobacillus, Bifidobacterium)
Unlike probiotic foods containing live microorganisms, the efficacy of probiotic nutraceuticals—such as those used to improve atopic dermatitis—has been scientifically validated to some extent. For optimal effectiveness, a probiotic nutraceutical should contain at least 5 to 10 billion colony-forming units per dose. In general, probiotics are well tolerated. Possible side effects include bloating, abdominal pain, and diarrhea.
Substance and mechanism of action: Probiotic nutraceuticals typically contain several million to billions of viable bacteria in powder form, predominantly Bifidobacteria and Lactobacilli. Probiotics can partially stimulate or modulate the mucosal immune system. Through various mechanisms, they stimulate the production of secretory immunoglobulins located in the intestinal lumen or on mucosal surfaces. Additionally, probiotic bacteria can inhibit the growth of competing, potentially pathogenic bacteria.
Evidence base: There is a considerable body of evidence regarding the effects of topical and oral probiotics on skin health. However, no substance-specific PCDB studies have been conducted. Many studies were conducted in children, with a significant variability in study quality. The beneficial effects are often weak and critically questioned in some publications, meaning the overall evidence is still insufficient (Table 4).
  • Galacto-Oligosaccharides
Galacto-oligosaccharides are classified as prebiotics. They are used as additives in various foods and are also found in breast milk. Nutraceuticals containing galacto-oligosaccharides (e.g., from whey) are typically consumed in doses of 2.5 to 10 g daily. Possible side effects, particularly at high doses, may include bloating, abdominal pain, and diarrhea.
Substance and mechanism of action: Galacto-oligosaccharides are reducing oligosaccharides consisting of one to seven galactose units and one glucose unit. They act as prebiotics by being “non-digestible food components that beneficially affect the host by selectively stimulating the growth and/or activity of one or more beneficial bacterial species in the colon, thus improving host health” (Gibson and Roberfroid, 1995 [317]). The stimulation of health-promoting bacteria leads to numerous beneficial effects, such as enhanced immune function, improved nutrient absorption, and the production of hydrogen as an antioxidant. In the context of skin health, the application of nutraceuticals containing galacto-oligosaccharides is suggested to reduce moisture loss and minimize wrinkle areas.
Evidence base: Previous studies suggest a significant improvement in skin properties (hydration and skin barrier function). However, the number of studies conducted is still quite limited, and most have been carried out in combination with Bifidobacteria. Thus, the efficacy of these nutraceuticals for supporting skin health remains insufficiently substantiated (Table 4).

3.2.6. Others

  • Coenzyme Q10
Coenzyme Q10 is an endogenous substance that is partly obtained from food but also synthesized in the body. In rare cases where the need for Q10 is elevated, nutraceuticals can help to prevent or compensate for a deficiency. A normal value for an adult is considered to be 0.85 µg/mL of coenzyme Q10 in plasma. The daily requirement for a normal-weight individual is approximately 50 mg (maintenance dose). The risk of overdose is low, as excess coenzyme Q10 is immediately converted to inactive forms and broken down. Symptoms such as abdominal pain, digestive disorders, and cold-like symptoms can occur only in cases of acute overdose of 1000 mg daily.
Substance and mechanism of action: Coenzyme Q10 is a naturally occurring ubiquinone produced by the body, found in mitochondria, blood, and cell membranes. As a nutraceutical, it is used to counteract skin aging and contribute to skin smoothness. Coenzyme Q10 plays a key role in cellular energy metabolism by participating in electron transfer in the respiratory chain and ATP production. It also has antioxidant properties, protecting membranes from oxidative damage.
Evidence base: The evidence base for nutraceuticals containing coenzyme Q10 is rather weak, as there are no clinical studies meeting scientific standards that demonstrate efficacy in relation to skin health beyond review articles. A PCDB study showed no significant reduction in skin wrinkles or improvement in skin smoothness (Table 4).

3.3. Group 3: Ingredients with Insufficiently Documented Effects

3.3.1. Vitamins

  • Vitamins B1, B2, B3, B5, B6, Vitamin D
The literature provides numerous indications that B vitamins, such as thiamine (Vitamin B1), riboflavin (Vitamin B2), niacinamide (Vitamin B3), pantothenic acid (Vitamin B5), and pyridoxine (Vitamin B6), play a significant role in skin health. For instance, a deficiency in thiamine may delay wound healing and impair the “maturation” of collagen fibers. A lack of riboflavin could promote the development of skin tumors, while pyridoxine deficiency may be associated with skin hypersensitivity. Supplementation with pantothenic acid is suggested to aid wound healing, and niacinamide is appreciated for its smoothing effects in cosmetic products. Vitamin D is widely used for alleviating atopic dermatitis and, often in conjunction with calcium, for maintaining bone health.
Substance and mechanism of action: The B vitamins comprise a group of eight water-soluble vitamins that serve as precursors for coenzymes. They are chemically and pharmacologically completely different substances found in both animal and plant foods, such as fish, liver, dairy products, broccoli, and spinach. Deficiency symptoms vary widely, from fatigue to skin rashes, inflammation, and even muscle wasting. Niacin is thought to help stabilize the skin’s barrier function, while vitamin D is well-known for its protective role against UV radiation.
The daily intake for niacin recommended by the DGE is between 13 and 18 mg. In Germany, this intake is typically exceeded by the standard diet, normally ensuring an adequate supply of niacin. When nicotinic acid is supplemented at high doses instead of nicotinamide, it can cause facial flushing, redness in the neck and arms, a sensation of heat, urticaria with intensely itchy wheals, and general skin itching, commonly referred to as “flushing symptoms”. Very high doses, reaching gram levels, can lead to diarrhea, nausea, vomiting, and even result in jaundice and liver damage. Supplements containing nicotinamide are typically offered in doses ranging from 50 to 500 mg per capsule. Unlike nicotinic acid, nicotinamide is not associated with flushing and exhibits very low hepatotoxicity.
Thiamine, as thiamine pyrophosphate, plays crucial roles as a coenzyme in decarboxylation reactions and is found in high concentrations in neurons as thiamine triphosphate (TTP). Pyridoxine, in its active form, pyridoxal phosphate, serves as a coenzyme involved in various biochemical reactions in cellular metabolism. Pantothenic acid is vital for the synthesis and breakdown of carbohydrates and fats as a component of coenzyme A and the acyl-carrier protein of fatty acid synthase. Pyridoxine, in its pyridoxal phosphate form, catalyzes elimination reactions, transaminations, and decarboxylations in amino acid metabolism. Niacin is an essential component of the coenzymes NAD+ and NADP+, which facilitate reversible hydrogen binding.
Evidence base: Despite the frequently described effects and an EFSA Health Claim for riboflavin and niacin concerning skin health (“…contributes to the maintenance of normal skin”), substantial clinical evidence supporting the efficacy of B vitamins (except biotin) or vitamin D as nutraceuticals for skin health is currently lacking. Most publications focus on the protective effects of these vitamins against UV radiation (Table 5).

3.3.2. Minerals and Trace Elements

  • Copper
Copper is an essential trace mineral obtained through the diet. The DGE recommends a daily intake of 1 to 1.5 mg of copper for healthy adults, although only about 25% of this amount can be absorbed. High concentrations of copper can lead to gastrointestinal disturbances, colic, or liver damage and may induce oxidative stress.
Substance and mechanism of action: As a trace element, copper is indispensable for the body, contributing to the elasticity, stability, and growth of connective tissues, bones, ligaments, tendons, and muscles. It is also vital for energy metabolism and melanin formation. Copper exhibits antioxidant properties and is required for collagen and elastin synthesis.
Copper is a key component of various enzymes, including monoamine oxidase, cytochrome c oxidase, and superoxide dismutase. Although copper deficiency is relatively rare due to sufficient dietary intake, it can occur in preterm infants and lead to impaired keratinization and pigmentation of hair. Copper appears to play a significant role as a cofactor in enzymatic reactions involved in the cross-linking of collagen fibers.
Evidence base: Copper is commonly found in various skin care products, particularly in the form of copper peptides, which are used to prevent age spots and wrinkle formation and to tighten connective tissue. There are two specific EFSA Health Claims for copper: “…contributes to normal skin pigmentation” and “…contributes to the maintenance of normal connective tissues”. However, substantial clinical studies and investigations supporting its use for skin health are still lacking (Table 5).
  • Selenium
Selenium is an essential trace element, present in the human body at levels of 5–15 mg as a component of various selenoproteins. The daily required intake is approximately 0.1 mg.
Substance and mechanism of action: Selenium is primarily ingested through organic compounds (e.g., selenocysteine) in the diet and is absorbed through the intestinal mucosa in proportion to the amount consumed. In the bloodstream, selenium is predominantly transported bound to selenoprotein P.
In addition to supporting pancreatic function, selenium is part of the amino acid selenocysteine, which acts as a cofactor for glutathione peroxidase and thyroxine-5′-deiodinase. Selenium deficiency is relatively uncommon in Europe and primarily manifests as impaired thyroid function and reduced antioxidant protection.
Evidence base: The EFSA has established a health claim for selenium regarding skin health: “Selenium contributes to the maintenance of normal skin, hair, and nails”. However, reliable clinical evidence for the effects of selenium on skin health, as mentioned in various reviews, has yet to be identified.

3.3.3. Secondary Natural Substances

  • Curcumin
Curcumin, the main component of turmeric, has been used in traditional Indian and Chinese medicine. In Ayurvedic medicine, it is employed to treat respiratory diseases, liver disorders, anorexia, rheumatism, and sinusitis, while traditional Chinese medicine uses it to alleviate abdominal pain. In the EU, health-related claims for (turmeric-containing) dietary supplements are not permitted.
Substance and mechanism of action: Curcumin is a polyphenol derived from the rhizome of the turmeric plant. It is believed to have anti-inflammatory, antioxidant, antimicrobial, and antimutagenic effects. The acceptable daily intake (ADI) is given as a maximum of 3 mg/kg body weight. Potential, albeit rare, side effects include diarrhea, headaches, skin rashes, and yellow stool discoloration.
Evidence base: Two meta-reviews have indicated that supplementation with curcumin-containing products may lower CRP levels. However, reliable data and studies specifically addressing its application for skin health are still lacking.

3.3.4. Plant and Animal Substances/Extracts

  • Phytosterols (excluding Aloe Sterols)
Phytosterols, also known as phytosterines, are secondary plant compounds classified as sterols. They primarily occur in fat-rich plant materials such as wheat germ, sunflower seeds, sesame, soybeans, and pumpkin seeds. In the context of benign prostatic hyperplasia, drugs, and specific dietary supplements are commercially available. There is evidence suggesting that phytosterols may impair the absorption of fat-soluble vitamins, resulting in reduced levels of carotene, vitamin E (α-tocopherol), and lycopene.
Substance and mechanism of action: Phytosterols are a group of chemical compounds found in plants, serving as structural components in plant cell membranes, similar to cholesterol in animal cell membranes. They are attributed with cholesterol-lowering, anti-atherogenic, and potentially anti-carcinogenic properties, though their precise mechanisms of action remain unclear. It is thought that phytosterols inhibit cholesterol absorption in the small intestine through competitive mechanisms. However, the BfR recommends limiting the consumption of phytosterol-enriched foods to individuals with elevated cholesterol levels due to a potentially increased atherogenic risk. Regarding skin health, it is assumed that orally ingested phytosterols are transported to the skin after absorption and contribute to the composition of surface lipids.
Evidence base: Studies demonstrating positive skin effects from the oral administration of phytosterols are still awaited (Table 5).
  • Bioactive Polysaccharides
Natural bioactive polysaccharides are regarded as effective modulators of the physiological structure, function, and health of the gastrointestinal tract. They are commonly used to treat inflammatory bowel diseases to exert immunomodulatory effects and certain beneficial impacts on the gut microbiota and its metabolites.
Substance and mechanism of action: Polysaccharides are carbohydrates consisting of a large number (at least eleven) of monosaccharides (simple sugars) linked by glycosidic bonds. This class of substances is widely distributed in nature and is needed for various functions, including energy storage, immune recognition structures, and molecular building blocks for the extracellular matrix.
Evidence base: Currently, only studies involving multi-ingredient formulations have been identified, making it difficult to draw conclusions about the effectiveness of individual substances (Table 5).
  • Serenoa Repens
Saw palmetto extract, derived from the fruit of the saw palmetto (Serenoa repens), is used as a herbal medicine for alleviating the symptoms of benign prostatic hyperplasia and for treating androgenetic alopecia.
Substance and mechanism of action: The main components of saw palmetto extract include phytosterols and plant oils containing free fatty acids. It also contains flavonoids, long-chain sugar molecules, and essential oils. The exact mechanisms of action are not yet fully elucidated. Anti-inflammatory and anti-androgenic effects attributed to the fatty acids and phytosterols are under discussion. Another potential mechanism involves the inhibition of 5-alpha-reductase, an enzyme that converts testosterone to dihydrotestosterone. Mild side effects, such as nausea, diarrhea, constipation, and sexual dysfunction, have been reported in connection with saw palmetto use.
Evidence base: Some studies suggest that Serenoa repens, when used as a standalone treatment compared to placebo, results in, at best, a small improvement in urinary symptoms or quality of life over three to six months. Positive effects were also noted in two smaller studies involving men with mild to moderate androgenetic alopecia. However, studies regarding its application for skin health are still lacking.

3.3.5. Probiotics and Prebiotics

  • Other Prebiotics
The targeted use of prebiotic substances in cosmetic products to support skin health by influencing the skin microbiome is increasingly pursued. Prebiotics aim to restore the balance of resident bacteria on human skin, which is important for both appearance and health. Utilizing the prebiotic principle, known from the food sector for specifically promoting gut microbiota to enhance immune function, pathogenic bacteria are inhibited while beneficial bacteria are fostered.
Substance and mechanism of action: Prebiotics are defined as indigestible food components that can be metabolized by specific bacteria in the intestinal microbiota. They are intended to specifically promote the growth of beneficial bacteria, thereby exerting positive effects on the health of the host.
Evidence base: Currently, robust scientific evidence or studies demonstrating the effectiveness of prebiotics in improving skin health are unavailable (Table 5).

3.3.6. Others

  • N-Acetylcysteine (NAC)
N-acetylcysteine (NAC) is primarily known for its oral, inhalative, and intravenous applications to liquefy mucus and facilitate its expulsion in chronic bronchopulmonary diseases associated with impaired mucus production and transport. Daily use is also claimed to benefit skin appearance.
Substance and mechanism of action: NAC is a prodrug form of L-cysteine and a precursor to glutathione, which is present in all cells of the body, particularly in erythrocytes. Glutathione plays a vital role as an antioxidant and enzyme cofactor. It helps neutralize free radicals, thus reducing oxidative stress. L-cysteine is also necessary for the biosynthesis of coenzyme A. The exact mechanism of action of NAC is not definitively established; its mucus-dissolving effect is believed to arise from the cleavage of polysaccharides in bronchial secretions.
Evidence base: Some studies have indicated that topical application of NAC can improve various skin parameters. However, sufficient scientific evidence regarding skin effects from oral NAC is still lacking. A PCDB study has been conducted, but it did not yield conclusive results (Table 5).

3.4. Combinations of Individual Substances

The majority of commercially available nutraceuticals aimed at supporting skin health contain more than one nutrient. A selection of common combinations is listed in Table 6. Amino acids, peptides, or plant extracts are often combined with vitamins and/or minerals to enhance or complement the positive effects of individual substances. However, this approach presents several issues: Generally, it is possible that the effects of individual substances may not necessarily synergize, and in some cases, even inhibitory interactions could occur. Therefore, positive effects observed from individual nutrients cannot automatically be assumed to apply to combinations of those nutrients (Table 3, Table 4 and Table 5).
A positive evidence rating is only assigned to combination products for which at least one product-specific randomized controlled trial is available. This applies to most of the products listed in Table 6, particularly to nutraceutical products combining collagen peptides or proteins with vitamins and often some other bioactive ingredients. To some extent, it also applies to products that include hyaluronic acid, amino acids, or specific plant extracts in combination with vitamins, minerals, or other functional ingredients.

3.5. Digestion and Absorption of Nutraceuticals

The bioavailability of nutraceuticals depends largely on their digestion, intestinal uptake, and subsequent transport. These processes vary considerably depending on the chemical nature, molecular size, and solubility of the compound. The review of the relevant literature has identified the following key mechanisms:
(a)
Modes of intake: Hydrophilic micronutrients (e.g., vitamin C, B vitamins, zinc) and peptides (e.g., collagen peptides) are typically taken in liquid, powder, or capsule form. Lipophilic substances (e.g., carotenoids, coenzyme Q10, omega-3 fatty acids) require fat-based formulations to support solubility and micelle formation. Polysaccharide-rich ingredients (e.g., aloe vera, hyaluronic acid) are commonly consumed as gels or liquid extracts. Formulation strongly affects dissolution and absorption.
(b)
Breakdown (digestion) processes: Proteins and polysaccharides undergo enzymatic digestion before absorption. Collagen peptides, though pre-hydrolyzed, are further degraded by pepsin and pancreatic enzymes into oligopeptides and amino acids. Polysaccharides like fiber or hyaluronic acid are largely indigestible and reach the colon, where gut microbiota may ferment them. Most micronutrients do not require digestive processing.
(c)
Transport and absorption mechanisms: Hydrophilic compounds use specific transporters: sodium–vitamin C co-transporters (SVCT), sodium-dependent multivitamin transporter (SMVT, e.g., for biotin and pantothenic acid), proton-coupled oligopeptide transporter 1 (PEPT1, for di- and tripeptides), and Zrt- and Irt-like protein 4 (ZIP4, for zinc). Lipophilic molecules are absorbed via passive diffusion from bile salt micelles, sometimes facilitated by transporters such as fatty acid translocase (FAT/CD36). Peptides such as collagen fragments are absorbed primarily via PEPT1.
(d)
Site of absorption: Most nutrients are absorbed in the duodenum and jejunum. Some, like vitamin B12, are absorbed in the ileum via receptor-mediated endocytosis. Microbially activated compounds (e.g., polyphenols) and polysaccharides primarily exert their physiological effects in the colon after undergoing microbial transformation.
(e)
Transport routes: Hydrophilic nutrients and small peptides enter the liver via the portal vein for further metabolism or distribution. Lipophilic compounds are incorporated into chylomicrons and reach systemic circulation via the lymphatic system. Non-absorbable components (e.g., fibers, probiotics) remain in the gastrointestinal tract and interact locally with gut cells or microbiota.
(f)
First-pass effect: Hydrophilic micronutrients, amino acids, and peptides may undergo partial first-pass metabolism in the liver. In contrast, lipophilic substances initially bypass hepatic metabolism via lymphatic transport but are eventually processed after chylomicron remnants are taken up by the liver.

3.6. Adverse Effects and Tolerability

Nutraceuticals, like all foods, medicines, and other preparations, can potentially trigger intolerances to individual or multiple ingredients. Allergic and immunogenic reactions, including anaphylactic shock, cannot be entirely ruled out. While the risk of side effects is generally assumed to be lower due to the relatively low dosages of ingredients and their typically minimal systemic efficacy compared to pharmaceuticals and other therapeutics, the likelihood of adverse effects increases with prolonged use and, in combination products, with the number of ingredients included.
The incidence of adverse effects from nutraceuticals can only be partially inferred from study results due to often limited participant numbers and inadequate study designs. Therefore, it is advisable to systematically document all reported suspected side effects using a “nutrivigilance” approach, similar to pharmacovigilance for pharmaceuticals, to identify potential clusters and associated risks.
Examples of adverse effects that are sometimes controversially discussed in the literature include the generation of oxidative stress at higher dosages of copper-containing products and an increased risk of lung cancer associated with beta-carotene (30 mg) after prolonged intake by smokers [318]. For fat-soluble vitamins, it is important to note that they can accumulate in the body and should generally be administered at relatively low doses.
Moreover, the use of polyphenols, despite their promising beneficial effects, is not always without potential risks. At higher doses, they may protect cancerous cells in addition to healthy cells, cause headaches or gastrointestinal side effects such as nausea, and even reach toxic levels, for instance, by inducing pro-oxidant effects [319].
Hyaluronic acid and its salts can cause intolerances, as well as allergic and immunogenic reactions. However, studies on beauty products containing hyaluronic acid have not reported any intolerances at the typical dosages used. Non-purified hyaluronic acid may contain endotoxins such as lipopolysaccharides. The hyaluronic acid found in supplements is typical of pharmaceutical quality and, thus, sufficiently pure. Hormone-mimetic substances like phytosterols may also lead to adverse effects, especially with prolonged use. Unlike nicotinamide, the intake of nicotinic acid can frequently lead to transient skin flushing (niacin flush), depending on various factors such as dosage, formulation, and medical condition. Accordingly, the recommended maximum daily dosages for the two substances differ significantly: 4 mg per day for nicotinic acid and 160 mg per day for nicotinamide [320].
The good tolerability of vitamins, minerals, trace elements, collagen peptides, fatty acids, and carbohydrates at the specified intake amounts has been demonstrated in selected studies and is particularly highlighted in reviews. The nutritional effects of these nutrients are generally not associated with side effects, even with prolonged intake. Natural substances like hyaluronic acid or curcumin are regarded with more caution in this regard.
The dosage form of nutraceuticals, such as gummies, chocolates, or similar products, should be viewed critically. So-called “beauty sweets” often suggest skin benefits through their ingredients, but they typically contain high sugar levels. Regular consumption of such products over an extended period contributes significantly to glycosylation, which can negatively affect skin quality [321].

4. Discussion

A closer examination of the data for more than 50 selected individual substances and combinations reveals that only a subset of these nutrients has scientifically validated efficacy in supporting skin health. The most important criterion is whether the benefits are supported by high-quality clinical studies, preferably including at least one substance-specific or product-specific PCDB study. The analysis has shown that the health claims formulated by the EFSA for certain nutraceuticals related to various aspects of skin health do not automatically allow for conclusions about the evidence base concerning skin health. A critical assessment of the evidence particularly applies to combination products, for which product-specific evidence is required.
It should be noted that the quality of studies may not always be satisfactorily assessed due to partially missing methodological details, which has led to downgrading evidence ratings in some cases. Moreover, due to the lack of clear dosage information in many studies, it cannot be ruled out that in individual cases, a dose that was too low has impeded the demonstration of efficacy.
The applications related to skin health emerge from the thoroughly described body of research. Original studies, reviews, and assessments facilitate the determination of purpose and suitability for various nutraceuticals. This documentation aims to present the available options for positively influencing skin health.
In this review, approximately 17 common dietary supplements or (groups of) substances for skin health, as well as some combination products, are identified as nutraceuticals with proven and sufficiently substantiated effects. These include vitamins A, B7, C, and E, collagen peptides, carotenoids, and several plant extracts. Other substances, despite many marketing claims and some existing health claims, were found to have limited (e.g., zinc, acerola) or insufficiently substantiated (e.g., many B vitamins, copper, curcumin) effects on skin health.
For various nutraceuticals where evidence from randomized controlled trials is insufficient or questionable, other forms of supporting data are available—such as non-RCT studies, positive assessments or indications from reviews, or even EFSA Health Claims related to skin health. In such cases, it seems appropriate to evaluate the full body of available evidence for each respective substance in order to determine whether it should be assigned to Group 2 (ingredients with less well-documented efficacy) or to Group 3 (ingredients with insufficiently documented effects). In this way, substances such as certain minerals, amino acids, plant extracts, and probiotics were assigned to Group 2, while ingredients, including, among others, certain vitamins, minerals, trace elements, and plant- or animal-derived compounds, were allocated to Group 3. For Biotin, vitamin E, and some polyphenols, it even appeared justified to assign them to Group 3 despite the lack of typical substance-specific RCT evidence, as at least one PCDB study in combination with vitamin A is available and the overall body of data is substantial.
The highlighted differences in the efficacy among these substances may serve as guidance for the targeted and successful use of these nutrients or nutrient complexes to support skin health. A differentiated consideration of efficacy, tolerability, and safety forms the basis for best practices in application.
To establish the efficacy of a combination product, specific studies are necessary. References to evidence from studies on individual substances alone are not sufficient due to potential additive, synergistic, and inhibitory effects; at best, they can only support the findings from product-specific studies. Therefore, it is generally recommended that for products with multiple ingredients, product-specific studies should be prioritized, preferably PCDB studies. This ensures the verification of the product in its specific composition, quality, and delivery form.
In favor of a wide range of nutraceuticals and a better overview of the associated literature, this review does not provide a comprehensive and detailed presentation of clinical data, in contrast to other reviews. It is based on published studies and other reviews but ultimately reflects the subjective assessment of the authors regarding the classification into evidence groups due to the heterogeneity and divergence of extensive data. For a more reliable assessment of the evidence, substance-related or product-specific clinical studies with recognized scientific design (RCT, PCDB) would be necessary for all evaluable nutraceuticals, which would significantly limit the number of products involved. It can be expected that in the coming years, the number of nutraceuticals available on the market to support skin health, as well as the number of clinical studies validating their efficacy, will continue to increase.

5. Conclusions

The data presented here regarding efficacy, tolerability, and safety demonstrate that nutraceuticals with strong evidence for their effectiveness are generally suitable for practical application regarding skin health. The unexpectedly low number of only 17 nutraceuticals with demonstrated efficacy—out of approximately 50 products evaluated- highlights a persistent gap between marketing claims and the actual scientific evidence supporting product effectiveness. On the other hand, many of the most widely used nutraceuticals, such as various vitamins, collagen peptides, omega-3 fatty acids, and hyaluronic acid, fall into the category of substances for which this review attests a sufficiently documented effect.
The number of clinical studies continues to increase year by year, which means that a reclassification might be required in the future—either upgrading the level of evidence in cases of positive clinical results or downgrading it if future studies fail to confirm efficacy. In principle, future evidence could also influence the safety profile of individual nutraceuticals, although—based on the current data—significant safety concerns appear unlikely for those products generally categorized as dietary supplements.
The proposed classification of nutraceuticals for skin health may support consumers and healthcare professionals in identifying products with a higher probability of clinical benefit. Nonetheless, many aspects of nutraceutical efficacy remain beyond the scope of this review, as a comprehensive comparison of the numerous commercially available products would exceed its intended focus. That said, several recent reviews have addressed other relevant properties of selected nutraceuticals and may offer answers to more specific questions.

Author Contributions

The initial literature review, as a basis for the selection and evaluation of the products under consideration, as well as the first drafting of the manuscript, was carried out by G.L. The other authors revised and expanded the manuscript. In this process, M.S. and E.P. provided expert evaluations of the nutraceuticals from cosmetic and dermatological perspectives, while J.-C.K. and B.P. assessed the products from a nutritional science perspective. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding. The APC was funded by QUIRIS Healthcare GmbH & Co. KG, Gütersloh, Germany.

Acknowledgments

Sponsorship for this review and Rapid Service Fee were funded by QUIRIS Healthcare GmbH & Co. KG, Gütersloh, Germany.

Conflicts of Interest

Although two authors are employees of the sponsor, the sponsor had no role in the preparation of the manuscript. All authors declare that the analyses, interpretations and conclusions presented in this manuscript have not been influenced by commercial interests of the sponsor and are the sole responsibility of the authors.

References

  1. Gupta, S.; Chauhan, D.; Mehla, K.; Sood, P.; Nair, A. An Overview of Nutraceuticals: Current Scenario. J. Basic Clin. Pharm. 2010, 1, 55–62. [Google Scholar] [PubMed]
  2. Chaudhari, S.; Powar, P.V.; Pratapwar, M.N. Nutraceuticals: A Review. World J. Pharm. Pharm. Sci. 2017, 6, 681–739. [Google Scholar] [CrossRef]
  3. Souyoul, S.A.; Saussy, K.P.; Lupo, M.P. Nutraceuticals: A Review. Dermatol. Ther. 2018, 8, 5–16. [Google Scholar] [CrossRef] [PubMed]
  4. Puri, V.; Nagpal, M.; Singh, I.; Singh, M.; Dhingra, G.A.; Huanbutta, K.; Dheer, D.; Sharma, A.; Sangnim, T. A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges. Nutrients 2022, 14, 4637. [Google Scholar] [CrossRef] [PubMed]
  5. Pérez-Sánchez, A.; Barrajón-Catalán, E.; Herranz-López, M.; Micol, V. Nutraceuticals for Skin Care: A Comprehensive Review of Human Clinical Studies. Nutrients 2018, 10, 403. [Google Scholar] [CrossRef]
  6. Vollmer, D.L.; West, V.A.; Lephart, E.D. Enhancing Skin Health: By Oral Administration of Natural Compounds and Minerals with Implications to the Dermal Microbiome. Int. J. Mol. Sci. 2018, 19, 3059. [Google Scholar] [CrossRef]
  7. Nwanodi, O. Skin Protective Nutraceuticals: The Current Evidence in Brief. Healthcare 2018, 6, 40. [Google Scholar] [CrossRef]
  8. Reeves, R.; Luks, E.L. Oral Supplements and Dermatology: A Review. Dermatol. Rev. 2024, 5, e239. [Google Scholar] [CrossRef]
  9. Morifuji, M. The Beneficial Role of Functional Food Components in Mitigating Ultraviolet-Induced Skin Damage. Exp. Dermatol. 2019, 28 (Suppl. 1), 28–31. [Google Scholar] [CrossRef]
  10. Shamloul, N.; Hashim, P.W.; Nia, J.J.; Farberg, A.S.; Goldenberg, G. The Role of Vitamins and Supplements on Skin Appearance. Cutis 2019, 104, 220–224. [Google Scholar]
  11. Dini, I.; Laneri, S. The New Challenge of Green Cosmetics: Natural Food Ingredients for Cosmetic Formulations. Molecules 2021, 26, 3921. [Google Scholar] [CrossRef] [PubMed]
  12. Sun, Q.; Wu, J.; Qian, G.; Cheng, H. Effectiveness of Dietary Supplement for Skin Moisturizing in Healthy Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front. Nutr. 2022, 9, 895192. [Google Scholar] [CrossRef]
  13. Januszewski, J.; Forma, A.; Zembala, J.; Flieger, M.; Tyczyńska, M.; Dring, J.C.; Dudek, I.; Świątek, K.; Baj, J. Nutritional Supplements for Skin Health—A Review of What Should Be Chosen and Why. Medicina 2023, 60, 68. [Google Scholar] [CrossRef] [PubMed]
  14. Birnbaum, J.; Buchner, L.; Le Moigne, A.; Dispensa, L. A Review of Clinical Trials Conducted With Oral, Multicomponent Dietary Supplements for Improving Photoaged Skin. J. Drugs. Dermatol. 2015, 14, 1453–1461. [Google Scholar]
  15. Mourelle, M.L.; Gómez, C.P.; Legido, J.L.; Pereira, L. Role of Nutribiotics in Skin Care. Appl. Sci. 2024, 14, 3505. [Google Scholar] [CrossRef]
  16. Assaf, S.; Kelly, O. Nutritional Dermatology: Optimizing Dietary Choices for Skin Health. Nutrients 2025, 17, 60. [Google Scholar] [CrossRef]
  17. Commission Regulation (EU) No 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health. Off. J. Eur. Union. 2012, L136, 1–40. Available online: https://eur-lex.europa.eu/eli/reg/2012/432/oj (accessed on 20 February 2025).
  18. Dau, A. Beauty Claims. Recht. Z. Eur. Leb. 2016, 4, 176–179. [Google Scholar]
  19. DeFelice, S.L. The Nutraceutical Revolution: Its Impact on Food Industry R&D. Trends. Food. Sci. Technol. 1995, 6, 59–61. [Google Scholar] [CrossRef]
  20. U.S. Food and Drug Administration (FDA). Dietary Supplement Health and Education Act (DSHEA). U.S. Department of Health and Human Services. Public Law 2017. pp. 103–417. Available online: https://ods.od.nih.gov/About/DSHEA_Wording.aspx (accessed on 20 February 2025).
  21. Santini, A.; Cammarata, S.M.; Capone, G.; Ianaro, A.; Tenore, G.C.; Pani, L.; Novellino, E. Nutraceuticals: Opening the Debate for a Regulatory Framework. Br. J. Clin. Pharmacol. 2018, 84, 659–672. [Google Scholar] [CrossRef]
  22. Zeisel, S.H. Regulation of ‘Nutraceuticals.’ U.S. FDA, Dietary Supplement Health and Education Act of 1994 (DSHEA). Science 1999, 285, 1853–1855. [Google Scholar] [CrossRef] [PubMed]
  23. Brower, V. Nutraceuticals: Poised for a Healthy Slice of the Healthcare Market? Nat. Biotechnol. 1998, 16, 728–731. [Google Scholar] [CrossRef] [PubMed]
  24. Merriam-Webster Online Dictionary; Merriam-Webster Inc.: Springfield, MA, USA, 2015.
  25. European Nutraceutical Association (ENA). Science Behind Nutraceuticals; Association, E.N., Ed.; European Nutraceutical Association: Basel, Switzerland, 2016; p. 594. [Google Scholar]
  26. Krutmann, J.; Bouloc, A.; Sore, G.; Bernard, B.A.; Passeron, T. The Skin Aging Exposome. J. Dermatol. Sci. 2017, 85, 152–161. [Google Scholar] [CrossRef] [PubMed]
  27. Mohd Ariffin, N.H.; Hasham, R. Assessment of Non-invasive Techniques and Herbal-Based Products on Dermatological Physiology and Intercellular Lipid Properties. Heliyon 2020, 6, e03955. [Google Scholar] [CrossRef]
  28. Abadie, S.; Bedos, P.; Rouquette, J. A Human Skin Model to Evaluate the Protective Effect of Compounds Against UVA Damage. Int. J. Cosmet. Sci. 2019, 41, 594–603. [Google Scholar] [CrossRef]
  29. Fink, B.; Matts, P.J.; Röder, S.; Johnson, R.; Burquest, M. Differences in Visual Perception of Age and Attractiveness of Female Facial and Body Skin. Int. J. Cosmet. Sci. 2011, 33, 126–131. [Google Scholar] [CrossRef]
  30. Goldie, K.; Kerscher, M.; Fabi, S.G.; Hirano, C.; Landau, M.; Lim, T.S.; Woolery-Lloyd, H.; Mariwalla, K.; Park, J.Y.; Yutskovskaya, Y. Skin Quality—A Holistic 360° View: Consensus Results. Clin. Cosmet. Investig. Dermatol. 2021, 14, 643–654. [Google Scholar] [CrossRef]
  31. Makrantonaki, E.; Vogel, M.; Scharffetter-Kochanek, K.; Zouboulis, C.C. Skin aging: Molecular understanding of extrinsic and intrinsic processes. Hautarzt 2015, 66, 730–737. (In German) [Google Scholar] [CrossRef]
  32. Cao, C.; Xiao, Z.; Wu, Y.; Ge, C. Diet and Skin Aging—From the Perspective of Food Nutrition. Nutrients 2020, 12, 870. [Google Scholar] [CrossRef]
  33. Petruk, G.; Del Giudice, R.; Rigano, M.M.; Monti, D.M. Antioxidants from Plants Protect Against Skin Photoaging. Oxidative Med. Cell. Longev. 2018, 2018, 1454936. [Google Scholar] [CrossRef]
  34. Kalra, E.K. Nutraceutical—Definition and introduction. AAPS Pharm. Sci. 2003, 5, E25. [Google Scholar] [CrossRef] [PubMed]
  35. Clair, J.S. A New Model of Tracheostomy Care: Closing the Research–Practice Gap. In Advances in Patient Safety: From Research to Implementation; Henriksen, K., Battles, J.B., Marks, E.S., Lewin, D.I., Eds.; Agency for Healthcare Research and Quality (US): Rockville, MD, USA, 2005; Volume 3. Available online: https://www.ncbi.nlm.nih.gov/books/NBK20542/ (accessed on 20 February 2025).
  36. Schölmerich, J. Medizinische Therapie, Sektion I Prinzipien der Therapie, Evidenzbasierte Medizin. In Medizinische Therapie; Schölmerich, J., Ed.; Springer: Berlin/Heidelberg, Germany, 2007; pp. 1–19. [Google Scholar]
  37. Oxford Centre for Evidence-Based Medicine. Levels of Evidence; Centre for Evidence-Based Medicine: Oxford, UK, 2009. [Google Scholar]
  38. GD Society for Dermopharmacy. Dermocosmetics Against Skin Aging: Guideline. Available online: https://www.gd-online.de/german/veranstalt/images2017/GD_LL_Dermokosmetika_gegen_Hautalterung_13.03.2017.pdf (accessed on 20 February 2025).
  39. Deutsche Gesellschaft für Ernährung e. V. (DGE). Referenzwerte für die Nährstoffzufuhr. 2019. Available online: http://www.dge.de/wissenschaft/referenzwerte/ (accessed on 20 February 2025).
  40. Genovese, L.; Sibilla, S. Innovative nutraceutical approaches to counteract the signs of aging. In Textbook of Aging Skin; Farage, M., Miller, K., Maibach, H., Eds.; Springer: Berlin/Heidelberg, Germany, 2016; pp. 1–25. [Google Scholar] [CrossRef]
  41. Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, Zinc; National Academy Press: Washington, DC, USA, 2001. [Google Scholar]
  42. Chauhan, B.; Kumar, G.; Kalam, N.; Ansari, S.H. Current concepts and prospects of herbal nutraceutical: A review. J. Adv. Pharm. Technol. Res. 2013, 4, 4–8. [Google Scholar] [PubMed]
  43. Bagchi, D. (Ed.) Nutraceutical and Functional Food Regulations in the United States and Around the World, 2nd ed.; Elsevier: Amsterdam, The Netherlands, 2014. [Google Scholar] [CrossRef]
  44. Weißenborn, A.; Bakhiya, N.; Demuth, I.; Ehlers, A.; Ewald, M.; Niemann, B.; Richter, K.; Trefflich, I.; Ziegenhagen, R.; Hirsch-Ernst, K.I.; et al. Höchstmengen für Vitamine und Mineralstoffe in Nahrungsergänzungsmitteln. J. Consum. Prot. Food. Saf. 2018, 13, 25–39. [Google Scholar] [CrossRef]
  45. Anderson, J.J. Oversupplementation of vitamin A and osteoporotic fractures in the elderly: To supplement or not to supplement with vitamin A. J. Bone Miner. Res. 2002, 17, 1359–1362. [Google Scholar] [CrossRef]
  46. Wintergerst, E.S.; Maggini, S.; Hornig, D.H. Contribution of selected vitamins and trace elements to immune function. Ann. Nutr. Metab. 2007, 51, 301–323. [Google Scholar] [CrossRef]
  47. Antille, C.; Tran, C.; Sorg, O.; Carraux, P.; Didierjean, L.; Saurat, J.H. Vitamin A exerts a photoprotective action in skin by absorbing ultraviolet B radiation. J. Investig. Dermatol. 2003, 121, 1163–1167. [Google Scholar] [CrossRef]
  48. Qu, Y.; Wang, Y.; Zhang, Y.; Han, C.; Gao, D.; Jin, W.; Liang, J.; Xia, X. The comparison of skin rejuvenation effects of vitamin A, fractional laser, their combination on rat. J. Cosmet. Laser Ther. 2019, 21, 19–27. [Google Scholar] [CrossRef]
  49. Kafi, R.; Kwak, H.S.; Schumacher, W.E.; Cho, S.; Hanft, V.N.; Hamilton, T.A.; King, A.L.; Neal, J.D.; Varani, J.; Fisher, G.J.; et al. Improvement of naturally aged skin with vitamin A (retinol). Arch. Dermatol. 2007, 143, 606–612. [Google Scholar] [CrossRef]
  50. Kikuchi, K.; Suetake, T.; Kumasaka, N.; Tagami, H. Improvement of photoaged facial skin in middle-aged Japanese females by topical retinol (vitamin A alcohol), A vehicle-controlled, double-blind study. J. Dermatol. Treat. 2009, 20, 276–281. [Google Scholar] [CrossRef]
  51. Gannon, B.; Kaliwile, C.; Arscott, S.A.; Schmaelzle, S.; Chileshe, J.; Kalungwana, N.; Mosonda, M.; Pixley, K.; Masi, C.; Tanumihardjo, S.A. Biofortified orange maize is as efficacious as a vitamin A supplement in Zambian children even in the presence of high liver reserves of vitamin A: A community-based, randomized placebo-controlled trial. Am. J. Clin. Nutr. 2014, 100, 1541–1545. [Google Scholar] [CrossRef]
  52. Ogawa, Y.; Kinoshita, M.; Sato, T.; Shimada, S.; Kawamura, T. Biotin is required for zinc homeostasis in the skin. Nutrients 2019, 11, 919. [Google Scholar] [CrossRef] [PubMed]
  53. Mock, D.M. Skin manifestations of biotin deficiency. Semin. Dermatol. 1991, 10, 296–302. [Google Scholar]
  54. Fernandez-Mejia, C.; Lazo-de-la-Vega-Monroy, M.-L. Biological effects of pharmacological concentrations of biotin. J. Evid. Based Complement. Altern. Med. 2011, 16, 40–48. [Google Scholar] [CrossRef]
  55. Thompson, K.G.; Kim, N. Dietary supplements in dermatology: A review of the evidence for zinc, biotin, vitamin D, nicotinamide, Polypodium. J. Am. Acad. Dermatol. 2021, 84, 1042–1050. [Google Scholar] [CrossRef]
  56. Frigg, M.; Schulze, J.; Völker, L. Clinical study on the effect of biotin on skin conditions in dogs. Schweiz. Arch. Tierheilkd. 1989, 131, 621–625. [Google Scholar] [PubMed]
  57. Boccaletti, V.; Zendri, E.; Giordano, G.; Gnetti, L.; De Panfilis, G. Familial uncombable hair syndrome: Ultrastructural hair study and response to biotin. Pediatr. Dermatol. 2007, 24, E14–E16. [Google Scholar] [CrossRef]
  58. Kalman, D.; Hewlings, S. A randomized double-blind evaluation of a novel biotin and silicon ingredient complex on the hair and skin of healthy women. J. Clin. Exp. Dermatol. Res. 2021, 12, 551. [Google Scholar]
  59. Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, Carotenoids; National Academy Press (US): Washington, DC, USA, 2000. [Google Scholar]
  60. NIH Office of Dietary Supplements. Vitamin C Fact Sheet for Health Professionals. Updated: 26 March 2021. Available online: https://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/ (accessed on 20 February 2025).
  61. Wang, K.; Jiang, H.; Li, W.; Qiang, M.; Dong, T.; Li, H. Role of vitamin C in skin diseases. Front. Physiol. 2018, 9, 819. [Google Scholar] [CrossRef]
  62. Tebbe, B.; Wu, S.; Geilen, C.C.; Eberle, J.; Kodelja, V.; Orfanos, C.E. L-ascorbic acid inhibits UVA-induced lipid peroxidation and secretion of IL-1α and IL-6 in cultured human keratinocytes. J. Investig. Dermatol. 1997, 108, 302–306. [Google Scholar] [CrossRef]
  63. Mireles-Rocha, H.; Galindo, I.; Huerta, M.; Trujillo-Hernández, B.; Elizalde, A.; Cortés-Franco, R. UVB photoprotection with antioxidants: Effects of oral therapy with d-α-tocopherol and ascorbic acid on the minimal erythema dose. Acta Derm. Venereol. 2002, 82, 21–24. [Google Scholar] [CrossRef] [PubMed]
  64. Bertuccelli, G.; Zerbinati, N.; Marcellino, M.; Nanda Kumar, N.S.; He, F.; Tsepakolenko, V.; Cervi, J.; Lorenzetti, A.; Marotta, F. Effect of a quality-controlled fermented nutraceutical on skin aging markers: An antioxidant-control, double-blind study. Exp. Ther. Med. 2016, 11, 909–916. [Google Scholar] [CrossRef]
  65. Lauer, A.C.; Groth, N.; Haag, S.F.; Darvin, M.E.; Lademann, J.; Meinke, M.C. Dose-dependent vitamin C uptake and radical scavenging activity in human skin measured with in vivo electron paramagnetic resonance spectroscopy. Ski. Pharmacol. Physiol. 2013, 26, 147–154. [Google Scholar] [CrossRef] [PubMed]
  66. McArdle, F.; Rhodes, L.E.; Parslew, R.; Jack, C.I.A.; Friedmann, P.S.; Jackson, M.J. UVR-induced oxidative stress in human skin in vivo: Effects of oral vitamin C supplementation. Free. Radic. Biol. Med. 2002, 33, 1355–1362. [Google Scholar] [CrossRef] [PubMed]
  67. Fuchs, J.; Kern, H. Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: A clinical study using solar simulated radiation. Free. Radic. Biol. Med. 1998, 25, 1006–1012. [Google Scholar] [CrossRef]
  68. Eberlein-König, B.; Placzek, M.; Przybilla, B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E). J. Am. Acad. Dermatol. 1998, 38, 45–48. [Google Scholar] [CrossRef]
  69. Evans, J.A.; Johnson, E.J. The role of phytonutrients in skin health. Nutrients 2010, 2, 903–928. [Google Scholar] [CrossRef]
  70. NIH Office of Dietary Supplements. Vitamin E Fact Sheet for Health Professionals 2017. Available online: https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/ (accessed on 20 February 2025).
  71. Maalouf, S.; El-Sabban, M.; Darwiche, N.; Gali-Muhtasib, H. Protective effect of vitamin E on ultraviolet B light-induced damage in keratinocytes. Mol. Carcinog. 2002, 34, 121–130. [Google Scholar] [CrossRef]
  72. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, Amino Acids; The National Academy Press: Washington, DC, USA, 2005. [Google Scholar] [CrossRef]
  73. Aung, T.; Halsey, J.; Kromhout, J.; Gerstein, L.R.; Marchioli, M.; Tavazzi, R.; Rauch, L.; Ness, B.; Bosch, A.; Collins, S. Associations of omega-3 fatty acid supplement use with cardiovascular disease risks. JAMA Cardiol. 2018, 3, 225–233. [Google Scholar] [CrossRef]
  74. Wang, P.; Sun, M.; Ren, J.; Djuric, Z.; Fisher, G.J.; Wang, X.; Li, Y. Gas chromatography-mass spectrometry analysis of effects of dietary fish oil on total fatty acid composition in mouse skin. Sci. Rep. 2017, 7, 42641. [Google Scholar] [CrossRef]
  75. Kendall, A.C.; Kiezel-Tsugunova, M.; Brownbridge, L.C.; Harwood, J.L.; Nicolaou, A. Lipid functions in skin: Differential effects of n-3 polyunsaturated fatty acids on cutaneous ceramides, in a human skin organ culture model. Biochim. Biophys. Acta 2017, 1859, 1679–1689. [Google Scholar] [CrossRef]
  76. Yoshida, S.; Yasutomo, K.; Watanabe, T. Treatment with DHA/EPA ameliorates atopic dermatitis-like skin disease by blocking LTB4 production. J. Med. Investig. 2016, 63, 187–191. [Google Scholar] [CrossRef]
  77. Yao, Q.; Jia, T.; Qiao, W.; Gu, H.; Kaku, K. Unsaturated fatty acid-enriched extract from Hippophae rhamnoides seed reduces skin dryness through up-regulating aquaporins 3 and hyaluronan synthetases 2 expressions. J. Cosmet. Dermatol. 2021, 20, 321–329. [Google Scholar] [CrossRef] [PubMed]
  78. Jackson, M.J.; McArdle, F.; Storey, A.; Jones, S.A.; McArdle, A.; Rhodes, L.E. Effects of micronutrient supplements on UV-induced skin damage. Proc. Nutr. Soc. 2002, 61, 187–189. [Google Scholar] [CrossRef] [PubMed]
  79. Orengo, I.F.; Black, H.S.; Wolf, J.E., Jr. Influence of fish oil supplementation on the minimal erythema dose in humans. Arch. Dermatol. Res. 1992, 284, 219–221. [Google Scholar] [CrossRef] [PubMed]
  80. Lassus, A.; Dahlgren, M.; Halpern, T.; Santalahti, J.; Happonen, H.P. Effects of dietary supplementation with polyunsaturated ethyl ester lipids (Angiosan) in patients with psoriasis and psoriatic arthritis. J. Int. Med. Res. 1990, 18, 68–73. [Google Scholar] [CrossRef]
  81. The ASCEND Study Collaborative Group. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. N. Engl. J. Med. 2018, 37, 1529–1539. [Google Scholar] [CrossRef]
  82. Rhodes, L.E.; Shahbakhti, H.; Azurdia, R.M.; Moison, R.M.W.; Steenwinkel, M.-J.S.T.; Homburg, M.I.; Dean, M.P.; McArdle, F.; Beijersbergen van Henegouwen, G.M.J.; Epe, B. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans: An assessment of early genotoxic markers. Carcinogenesis 2003, 24, 919–925. [Google Scholar] [CrossRef]
  83. Wright, S.; Burton, J.L. Oral evening primrose seed oil improves atopic eczema. Lancet 1982, 320, 1120–1122. [Google Scholar] [CrossRef]
  84. Rabionet, M.; Gorgas, K.; Sandhoff, R. Ceramide synthesis in the epidermis. Biochim. Biophys. Acta 2014, 1841, 422–434. [Google Scholar] [CrossRef]
  85. Tessema, E.N.; Gebre-Mariam, T.; Neubert, R.H.H.; Wohlrab, J. Potential applications of phyto-derived ceramides in improving epidermal barrier function. Skin. Pharmacol. Physiol. 2017, 30, 115–138. [Google Scholar] [CrossRef] [PubMed]
  86. Uchida, Y.; Park, K. Ceramides in skin health and disease: An update. Am. J. Clin. Dermatol. 2021, 22, 853–866. [Google Scholar] [CrossRef] [PubMed]
  87. Bedja, D.; Yan, M.; Ge, S.E.; Zhao, S.Z.; Dawson, J.M.; Gabrielson, D.A. Inhibition of glycosphingolipid synthesis reverses skin inflammation and hair loss in ApoE−/− mice fed a western diet. Sci. Rep. 2018, 8, 11463. [Google Scholar] [CrossRef]
  88. Kimata, H. Improvement of atopic dermatitis and reduction of skin allergic responses by oral intake of konjac ceramide. Pediatr. Dermatol. 2006, 23, 386–389. [Google Scholar] [CrossRef] [PubMed]
  89. Miyanishi, K.; Shiono, N.; Shirai, H.; Dombo, M.; Kimata, H. Reduction of transepidermal water loss by oral intake of glucosylceramides in patients with atopic eczema. Allergy 2005, 60, 1454–1455. [Google Scholar] [CrossRef]
  90. Uchiyama, T.; Nakano, Y.; Ueda, O.; Mori, H.; Nakashima, M.; Noda, A.; Ishizaki, C.; Mizoguchi, M. Oral intake of glucosylceramide improves relatively higher levels of transepidermal water loss in mice and healthy human subjects. J. Health. Sci. 2008, 54, 559–566. [Google Scholar] [CrossRef]
  91. Guillou, S.; Ghabri, S.; Jannot, C.; Gaillard, E.; Lamour, I.; Boisnic, S. The moisturizing effect of a wheat extract food supplement on women’s skin: A randomized, double-blind placebo-controlled trial. Int. J. Cosmet. Sci. 2011, 33, 138–143. [Google Scholar] [CrossRef] [PubMed]
  92. Bizot, V.; Cestone, E.; Michelotti, A.; Nobile, V. Improving skin hydration and age-related symptoms by oral administration of wheat glucosylceramides and digalactosyl diglycerides: A human clinical study. Cosmetics 2017, 4, 37. [Google Scholar] [CrossRef]
  93. Choi, F.D.; Sung, C.T.; Juhasz, M.L.W.; Mesinkovsk, N.A. Oral collagen supplementation: A systematic review of dermatological applications. J. Drugs. Dermatol. 2019, 18, 9–16. [Google Scholar]
  94. Bella, J. Collagen structure: New tricks from a very old dog. Biochem. J. 2016, 473, 1001–1025. [Google Scholar] [CrossRef]
  95. Bella, J.; Hulmes, D.J. Fibrillar collagens. Subcell. Biochem. 2017, 82, 457–490. [Google Scholar] [CrossRef] [PubMed]
  96. Sibilla, S.; Godfrey, M.; Brewer, S.; Budh-Raja, A.; Genovese, L. An overview of the beneficial effects of hydrolyzed collagen as a nutraceutical on skin properties: Scientific background and clinical studies. Open Nutraceuticals J. 2015, 8, 29–42. [Google Scholar] [CrossRef]
  97. Zague, V. A new view concerning the effects of collagen hydrolysate intake on skin properties. Arch. Dermatol. Res. 2008, 300, 479–483. [Google Scholar] [CrossRef]
  98. Genovese, L.; Corbo, A.; Sibilla, S. An insight into the changes in skin texture and properties following dietary intervention with a nutricosmeceutical containing a blend of collagen bioactive peptides and antioxidants. Ski. Pharmacol. Physiol. 2017, 30, 146–158. [Google Scholar] [CrossRef]
  99. Zhao, X.; Zhang, X.; Liu, D. Collagen peptides and the related synthetic peptides: A review on improving skin health. J. Funct. Foods 2021, 86, 104680. [Google Scholar] [CrossRef]
  100. De Miranda, R.B.; Weimer, P.; Rossi, R.C. Effects of hydrolyzed collagen supplementation on skin aging: A systematic review and meta-analysis. Int. J. Dermatol. 2021, 60, 1449–1461. [Google Scholar] [CrossRef] [PubMed]
  101. Al-Atif, H. Collagen supplements for aging and wrinkles: A paradigm shift in the fields of dermatology and cosmetics. Dermatol. Pract. Concept. 2022, 12, e2022018. [Google Scholar] [CrossRef]
  102. Shenoy, M.; Abdul, N.S.; Qamar, Z.; Bahri, B.M.A.; Al Ghalayini, K.Z.K.; Kakti, A. Collagen structure, synthesis, its applications: A systematic review. Cureus 2022, 14, e24856. [Google Scholar] [CrossRef]
  103. Pu, S.Y.; Huang, Y.L.; Pu, C.M. Efficacy of collagen peptide supplementation in improving skin elasticity and reducing wrinkles: A review of clinical trials. J. Cosmet. Dermatol. 2021, 20, 1012–1020. [Google Scholar] [CrossRef]
  104. Dewi, D.A.R.; Arimuko, A.; Norawati, L.; Yenny, S.W.; Setiasih, N.L.; Perdiyana, A.; Arkania, N.; Nadhira, F.; Wiliantari, N. Exploring the Impact of Hydrolyzed Collagen Oral Supplementation on Skin Rejuvenation: A Systematic Review and Meta-Analysis. Cureus 2023, 15, e50231. [Google Scholar] [CrossRef]
  105. Liu, H.; Dong, J.; Du, R.; Gao, Y.; Zhao, P. Collagen study advances for photoaging skin. Photodermatol. Photoimmunol. Photomed. 2024, 40, e12931. [Google Scholar] [CrossRef]
  106. Buckley, M. Species Identification of Bovine, Ovine and Porcine Type 1 Collagen; Comparing Peptide Mass Fingerprinting and LC-Based Proteomics Methods. Int. J. Mol. Sci. 2016, 17, 445. [Google Scholar] [CrossRef] [PubMed]
  107. Hong, H.; Fan, H.; Chalamaiah, M.; Wu, J. Preparation of low-molecular-weight, collagen hydrolysates (peptides), Current progress, challenges, future perspectives. Food. Chem. 2019, 301, 125222. [Google Scholar] [CrossRef] [PubMed]
  108. León-López, A.; Morales-Peñaloza, A.; Martínez-Juárez, V.M.; Vargas-Torres, A.; Zeugolis, D.I.; Aguirre-Álvarez, G. Hydrolyzed Collagen—Sources and Applications. Molecules 2019, 24, 4031. [Google Scholar] [CrossRef] [PubMed]
  109. López-Morales, C.A.; Vázquez-Leyva, S.; Vallejo-Castillo, L.; Carballo-Uicab, G.; Muñoz-García, L.; Herbert-Pucheta, J.E.; Zepeda-Vallejo, L.G.; Velasco-Velázquez, M.; Pavón, L.; Pérez-Tapia, S.M.; et al. Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. J. Food. Sci. 2019, 84, 430–439. [Google Scholar] [CrossRef]
  110. Feng, M.; Betti, M. Transepithelial transport efficiency of bovine collagen hydrolysates in a human Caco-2 cell line model. Food. Chem. 2017, 224, 242–250. [Google Scholar] [CrossRef]
  111. Pentzien, A.-K.; Zellchemische Untersuchungen der Wirkung von Peptiden und Proteinhydrolysaten auf Humanzellen. Institut für Chemie und Technologie der Milch der Bundesanstalt für Ernährung und Lebensmittel 2005. Available online: https://macau.uni-kiel.de/servlets/MCRFileNodeServlet/dissertation_derivate_00001669/d1669.pdf (accessed on 20 February 2025).
  112. Zague, V.; do Amaral, J.B.; Rezende Teixeira, P.; de Oliveira Niero, E.L.; Lauand, C.; Machado-Santelli, G.M. Collagen peptides modulate the metabolism of extracellular matrix by human dermal fibroblasts derived from sun-protected and sun-exposed body sites. Cell Biol. Int. 2018, 42, 95–104. [Google Scholar] [CrossRef]
  113. Oba, C.; Ohara, H.; Morifuji, M.; Ito, K.; Ichikawa, S.; Kawahata, K.; Koga, J. Collagen hydrolysate intake improves the loss of epidermal barrier function and skin elasticity induced by UVB irradiation in hairless mice. Photodermatol. Photoimmunol. Photomed. 2013, 29, 204–211. [Google Scholar] [CrossRef]
  114. Haratake, N.; Watase, D.; Fujita, T.; Setoguchi, S.; Matsunaga, K.; Takata, J. Effects of oral administration of collagen peptides on skin collagen content and its underlying mechanism using a newly developed low collagen skin mice model. J. Funct. Foods 2015, 16, 174–182. [Google Scholar] [CrossRef]
  115. Watanabe-Kamiyama, M.; Shimizu, M.; Kamiyama, S.; Taguchi, Y.; Sone, H.; Morimatsu, F.; Shirakawa, H.; Furukawa, Y.; Komai, M. Absorption and effectiveness of orally administered low molecular weight collagen in rats. J. Agric. Food Chem. 2010, 58, 835–841. [Google Scholar] [CrossRef]
  116. Hakuta, A.; Yamaguchi, Y.; Okawa, T.; Yamamoto, S.; Sakai, Y.; Aihara, M. Anti-inflammatory effect of collagen tripeptide in atopic dermatitis. J. Dermatol. Sci. 2017, 87, 201–203. [Google Scholar] [CrossRef] [PubMed]
  117. Lee, H.J.; Jang, H.-L.; Ahn, D.-K.; Kim, H.-J.; Jeon, H.Y.; Seo, D.B.; Lee, J.-H.; Choi, J.K.; Kang, S.-S. Orally administered collagen peptide protects against UVB-induced skin aging through the absorption of dipeptide forms, Gly-Pro and Pro-Hyp. Biosci. Biotechnol. Biochem. 2019, 83, 1146–1156. [Google Scholar] [CrossRef]
  118. Kerscher, M.; Streker, M.; Eiben-Nielson, C.; Thill, M.S. Influence of oral collagen peptide intake on relevant skin parameters such as skin hydration, elasticity, roughness. In Proceedings of the IMCAS World Congress 2018, Paris, France, 1–3 February 2018. [Google Scholar]
  119. Bolke, L.; Kattenstroth, J.C. Influence of oral collagen-peptide intake on skin hydration and density. 6.2: Topic and Oral Supplements. In Proceedings of the 9th International Conference on Skin Ageing & Challenges, Track 2018, Porto, Potugal, 26–27 February 2018. [Google Scholar]
  120. Streker, M.; Thill, M.S.; Kerscher, M. Impact of oral collagen-peptides on skin quality. Akt. Dermatol. 2020, 46, 87–93. [Google Scholar] [CrossRef]
  121. Addor, F.A.S.A.; Vieira, J.C.; Melo, C.S.A. Improvement of dermal parameters in aged skin after oral use of a nutrient supplement. Clin. Cosmet. Investig. Dermatol. 2018, 11, 195–201. [Google Scholar] [CrossRef] [PubMed]
  122. Schlippe, G.; Bolke, L.; Voss, W. Einfluss oraler Einnahme von Kollagenpeptiden auf relevante Parameter der Hautalterung: Hautfeuchtigkeit, Hautelastizität und Hautrauigkeit. Akt. Dermatol. 2015, 41, 529–534. [Google Scholar]
  123. Dähnhardt, D.; Dähnhardt-Pfeiffer, S.; Segger, D.; Poeggeler, B.; Lemmnitz, G. Restoration of the ultrastructural integrity of the dermal collagen network by 12-week ingestion of special collagen peptides. Dermatol. Ther. 2024, 14, 2509–2521. [Google Scholar] [CrossRef]
  124. Borumand, M.; Sibilla, S. Daily consumption of the collagen supplement Pure Gold Collagen® reduces visible signs of aging. Clin. Interv. Aging 2014, 9, 1747–1758. [Google Scholar] [CrossRef]
  125. Campos, P.M.; Melo, M.O.; Calixto, M.M.; Fossa, L.S. An oral supplementation based on hydrolyzed collagen and vitamins improves skin elasticity and dermis echogenicity: A clinical placebo-controlled study. Clin. Pharmacol. Biopharm. 2015, 4, 1–6. [Google Scholar] [CrossRef]
  126. Nomoto, T.; Iizaka, S. Effect of an oral nutrition supplement containing collagen peptides on stratum corneum hydration and skin elasticity in hospitalized older adults: A multicenter open-label randomized controlled study. Adv. Ski. Wound Care 2020, 33, 186–191. [Google Scholar] [CrossRef]
  127. Samadi, A.; Movafaghi, M.; Kazemi, F.; Yazdanparast, T.; Ahmad Nasrollahi, S.; Firooz, A. Tolerability and efficacy assessment of an oral collagen supplement for the improvement of biophysical and ultrasonographic parameters of skin in Middle Eastern consumers. J. Cosmet. Dermatol. 2023, 22, 2252–2258. [Google Scholar] [CrossRef]
  128. Bianchi, F.M.; Angelinetta, C.; Rizzi, G.; Praticò, A.; Villa, R. Evaluation of the efficacy of a hydrolyzed collagen supplement for improving skin moisturization, smoothness, wrinkles. J. Clin. Aesthet. Dermatol. 2022, 15, 48–52. [Google Scholar] [PubMed]
  129. Skov, K.; Oxfeldt, M.; Thogersen, R.; Hansen, M.; Bertram, H.C. Enzymatic hydrolysis of a collagen hydrolysate enhances postprandial absorption rate: A randomized controlled trial. Nutrients 2019, 11, 1064. [Google Scholar] [CrossRef] [PubMed]
  130. Proksch, E.; Segger, D.; Degwert, J.; Schunck, M.; Zague, V.; Oesser, S. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: A double-blind, placebo-controlled study. Ski. Pharmacol. Physiol. 2014, 27, 47–55. [Google Scholar] [CrossRef] [PubMed]
  131. Proksch, E.; Schunck, M.; Zague, V.; Segger, D.; Degwert, J.; Oesser, S. Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis. Ski. Pharmacol. Physiol. 2014, 27, 113–119. [Google Scholar] [CrossRef]
  132. Schunck, M.; Zague, V.; Oesser, S.; Proksch, E. Dietary supplementation with specific collagen peptides has a body mass index-dependent beneficial effect on cellulite morphology. J. Med. Food 2015, 18, 1340–1348. [Google Scholar] [CrossRef]
  133. Asserin, J.; Lati, E.; Shioya, T.; Prawitt, J. The effect of oral collagen peptide supplementation on skin moisture and the dermal collagen network: Evidence from an ex vivo model and randomized, placebo-controlled clinical trials. J. Cosmet. Dermatol. 2015, 14, 291–301. [Google Scholar] [CrossRef] [PubMed]
  134. Jung, K.; Kim, S.H.; Joo, K.M.; Lim, S.H.; Shin, J.H.; Roh, J.; Kim, E.; Park, C.W.; Kim, W. Oral intake of enzymatically decomposed AP collagen peptides improves skin moisture and ceramide and natural moisturizing factor contents in the stratum corneum. Nutrients 2021, 13, 4372. [Google Scholar] [CrossRef]
  135. Choi, S.Y.; Ko, E.J.; Lee, Y.H.; Kim, B.G.; Shin, H.J.; Seo, D.B.; Lee, S.J.; Kim, B.J.; Kim, M.N. Effects of collagen tripeptide supplement on skin properties: A prospective, randomized, controlled study. J. Cosmet. Laser Ther. 2014, 16, 132–137. [Google Scholar] [CrossRef]
  136. Miyanaga, M.; Uchiyama, T.; Motoyama, A.; Ochiai, N.; Ueda, O.; Ogo, M. Oral supplementation of collagen peptides improves skin hydration by increasing the natural moisturizing factor content in the stratum corneum: A randomized, double-blind, placebo-controlled clinical trial. Ski. Pharmacol. Physiol. 2021, 34, 115–127. [Google Scholar] [CrossRef]
  137. Kim, J.; Lee, S.G.; Lee, J.; Choi, S.; Suk, J.; Lee, J.H.; Yang, J.H.; Yang, J.S.; Kim, J. Oral supplementation of low-molecular-weight collagen peptides reduces skin wrinkles and improves biophysical properties of skin: A randomized, double-blinded, placebo-controlled study. J. Med. Food. 2022, 25, 1146–1154. [Google Scholar] [CrossRef]
  138. Inoue, N.; Sugihara, F.; Wang, X. Ingestion of bioactive collagen hydrolysates enhances facial skin moisture and elasticity and reduces facial aging signs in a randomized double-blind placebo-controlled clinical study. J. Sci. Food Agric. 2016, 96, 4417–4425. [Google Scholar] [CrossRef] [PubMed]
  139. Sibilla, S.; Borumand, M. Effects of a nutritional supplement containing collagen peptides on skin elasticity, hydration, wrinkles. J. Med. Nutr. Nutraceuticals 2015, 4, 47–53. [Google Scholar] [CrossRef]
  140. Czajka, A.; Kania, E.M.; Genovese, L.; Corbo, A.; Merone, G.; Luci, C.; Sibilla, S. Daily oral supplementation with collagen peptides combined with vitamins and other bioactive compounds improves skin elasticity and has a beneficial effect on joint and general wellbeing. Nutr. Res. 2018, 57, 97–108. [Google Scholar] [CrossRef] [PubMed]
  141. Laing, S.; Bielfeldt, S.; Ehrenberg, C.; Wilhelm, K. A dermonutrient containing special collagen-peptides improves skin structure and function: A randomized, placebo-controlled, triple-blind trial using confocal laser scanning microscopy on the cosmetic effects and tolerance of a drinkable collagen supplement. J. Med. Food 2020, 23, 147–152. [Google Scholar] [CrossRef]
  142. Bolke, L.; Schlippe, G.; Gerß, J.; Voss, W. A collagen supplement improves skin hydration, elasticity, roughness, density: Results of a randomized, placebo-controlled, blind study. Nutrients 2019, 11, 2494. [Google Scholar] [CrossRef]
  143. Lee, K.S.; Posthauer, M.E.; Dorner, B.; Redovian, V.; Maloney, M.J. Pressure ulcer healing with a concentrated, fortified, collagen protein hydrolysate supplement: A randomized controlled trial. Adv. Ski. Wound. Care 2006, 19, 92–96. [Google Scholar] [CrossRef]
  144. Mödinger, Y.; Schön, C.; Vogel, K.; Brandt, M.; Bielfeldt, S.; Wilhelm, K.-P. Evaluation of a food supplement with collagen hydrolysate and micronutrients on skin appearance and beauty effects: A randomized, double-blind, placebo-controlled clinical study with healthy subjects. J. Clin. Cosmet. Dermatol. 2021, 4, 1–5. [Google Scholar] [CrossRef]
  145. Ito, N.; Seki, S.; Ueda, F. Effects of composite supplement containing collagen peptide and ornithine on skin conditions and plasma IGF-1 levels—A randomized, double-blind, placebo-controlled trial. Mar. Drugs 2018, 16, 482. [Google Scholar] [CrossRef]
  146. Gibson, R.; Krug, L.; Ramsey, D.L.; Safaei, A.; Aspley, S. Beneficial effects of multi-micronutrient supplementation with collagen peptides on global wrinkles, skin elasticity, appearance in healthy female subjects. Dermatol. Ther. 2024, 14, 1599–1614. [Google Scholar] [CrossRef]
  147. Vleminckx, S.; Virgilio, N.; Asserin, J.; Prawitt, J.; Silva, C.I.F. Influence of collagen peptide supplementation on visible signs of skin and nail health and aging in an East Asian population: A double-blind, randomized, placebo-controlled trial. J. Cosmet. Dermatol. 2024, 23, 3645–3653. [Google Scholar] [CrossRef]
  148. Yoon, H.-S.; Cho, H.H.; Cho, S.; Lee, S.-R.; Shin, M.-H.; Chung, J.H. Supplementing with dietary astaxanthin combined with collagen hydrolysate improves facial elasticity and decreases matrix metalloproteinase-1 and -12 expression: A comparative study with placebo. J. Med. Food 2017, 17, 810–816. [Google Scholar] [CrossRef]
  149. Geahchan, S.; Baharlouei, P.; Rahman, A. Marine Collagen: A Promising Biomaterial for Wound Healing, Skin Anti-Aging, Bone Regeneration. Mar. Drugs 2022, 20, 61. [Google Scholar] [CrossRef] [PubMed]
  150. Cruz, M.A.; Araujo, T.A.; Avanzi, I.R.; Parisi, J.R.; de Andrade, A.L.M.; Rennó, A.C.M. Collagen from Marine Sources and Skin Wound Healing in Animal Experimental Studies: A Systematic Review. Mar. Biotechnol. 2021, 23, 1–11. [Google Scholar] [CrossRef]
  151. Cadar, E.; Pesterau, A.M.; Prasacu, I.; Ionescu, A.M.; Pascale, C.; Dragan, A.L.; Sirbu, R.; Tomescu, C.L. Marine Antioxidants from Marine Collagen and Collagen Peptides with Nutraceuticals Applications: A Review. Antioxidants 2024, 13, 919. [Google Scholar] [CrossRef] [PubMed]
  152. Yao, W.; Zhang, Y.; Zhang, G. Marine peptides as potential anti-aging agents: Preparation, characterization, mechanisms of action, future perspectives. Food. Chem. 2024, 460 Pt 1, 140413. [Google Scholar] [CrossRef] [PubMed]
  153. Guo, L.; Harnedy, P.A.; Zhang, L.; Li, B.; Zhang, Z.; Hou, H.; Zhao, X.; FitzGerald, R.J. In vitro assessment of the multifunctional bioactive potential of Alaska pollock skin collagen following simulated gastrointestinal digestion. J. Sci. Food Agric. 2015, 95, 1514–1520. [Google Scholar] [CrossRef]
  154. Evans, M.; Lewis, E.D.; Zakaria, N.; Pelipyagina, T.; Guthrie, N. A randomized, triple-blind, Plazebo-controlled, parallel study to evaluate the efficacy of a freshwater marine collagen on skin wrinkles and elasticity. J. Cosmet. Dermatol. 2021, 20, 825–834. [Google Scholar] [CrossRef]
  155. Maia Campos, P.M.B.G.; Franco, R.S.B.; Kakuda, L.; Cadioli, G.F.; Costa, G.M.D.; Bouvret, E. Oral Supplementation with Hydrolyzed Fish Cartilage Improves the Morphological and Structural Characteristics of the Skin: A Double-Blind, Plazebo-Controlled Clinical Study. Molecules 2021, 26, 4880. [Google Scholar] [CrossRef]
  156. Lee, M.; Kim, E.; Ahn, H.; Son, S.; Lee, H. Oral intake of collagen peptide NS improves hydration, elasticity, desquamation, wrinkling in human skin: A randomized, double-blinded, placebo-controlled study. Food Funct. 2023, 14, 3196–3207. [Google Scholar] [CrossRef]
  157. Seong, S.H.; Lee, Y.I.; Lee, J.; Choi, S.; Kim, I.A.; Suk, J.; Jung, I.; Baeg, C.; Kim, J.; Oh, D.; et al. Low-molecular-weight collagen peptides supplement promotes a healthy skin: A randomized, double-blinded, Placebo-controlled study. J. Cosmet. Dermatol. 2024, 23, 554–562. [Google Scholar] [CrossRef]
  158. De Luca, C.; Mikhal’chik, E.V.; Suprun, M.V.; Papacharalambous, M.; Truhanov, A.I.; Korkina, L.G. Skin antiageing and systemic redox effects of supplementation with marine collagen peptides and plant-derived antioxidants: A single-blind case-control clinical study. Oxidative Med. Cell. Longev. 2016, 2016, 4389410. [Google Scholar] [CrossRef] [PubMed]
  159. Bhadra, B.; Sakpal, A.; Patil, S.; Patil, S.; Date, A.; Prasad, V.; Dasgupta, S. A Guide to Collagen Sources, Applications and Current Advancements. Syst. Biosci. Eng. 2021, 1, 67–68. [Google Scholar] [CrossRef]
  160. Cao, C.; Xiao, Z.; Tong, H.; Liu, Y.; Wu, Y.; Ge, C. Oral Intake of Chicken Bone Collagen Peptides Anti-Skin Aging in Mice by Regulating Collagen Degradation and Synthesis, Inhibiting Inflammation and Activating Lysosomes. Nutrients 2022, 14, 1622. [Google Scholar] [CrossRef]
  161. Gojkovic, Z.; Marova, I.; Matouskova, P.; Obruca, S.; Miloslav, P. Use of ultrasonic spectroscopy and viscosimetry for the characterization of chicken skin collagen in comparison with collagens from other animal tissues. Prep. Biochem. Biotechnol. 2014, 44, 761–771. [Google Scholar] [CrossRef]
  162. Kalman, D.S.; Hewlings, S. The effect of oral hydrolyzed eggshell membrane on the appearance of hair, skin, nails in healthy middle-aged adults: A randomized double-blind Plazebo-controlled clinical trial. J. Cosmet. Dermatol. 2020, 19, 1463–1472. [Google Scholar] [CrossRef] [PubMed]
  163. Schwartz, S.R.; Hammon, K.A.; Gafner, A.; Dahl, A.; Guttman, N.; Fong, M.; Schauss, A.G. Novel Hydrolyzed Chicken Sternal Cartilage Extract Improves Facial Epidermis and Connective Tissue in Healthy Adult Females: A Randomized, Double-Blind, Plazebo-Controlled Trial. Altern. Ther. Health. Med. 2019, 25, 12–29. [Google Scholar] [PubMed]
  164. Mohammed, A.; He, S. A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy of a Hydrolyzed Chicken Collagen Type II Supplement in Alleviating Joint Discomfort. Nutrients 2021, 13, 2454. [Google Scholar] [CrossRef]
  165. Hewlings, S.; Kalman, D.; Schneider, L.V. A Randomized, Double-Blind, Placebo-Controlled, Prospective Clinical Trial Evaluating Water-Soluble Chicken Eggshell Membrane for Improvement in Joint Health in Adults with Knee Osteoarthritis. J. Med. Food 2019, 22, 875–884. [Google Scholar] [CrossRef]
  166. Lin, Y.-K.; Liang, C.-H.; Lin, Y.-H.; Lin, T.-W.; Jiménez Vázquez, J.; van Campen, A.; Chiang, C.-F. Oral Supplementation of Vegan Collagen Biomimetic Has Beneficial Effects on Human Skin Physiology: A Double-Blind, Placebo-Controlled Study. J. Funct. Foods 2024, 112, 105955. [Google Scholar] [CrossRef]
  167. Fiedor, J.; Burda, K. Potential Role of Carotenoids as Antioxidants in Human Health and Disease. Nutrients 2014, 6, 466–488. [Google Scholar] [CrossRef]
  168. Stahl, W.; Sies, H. β-Carotene and Other Carotenoids in Protection from Sunlight. Am. J. Clin. Nutr. 2012, 96, 1179S–1184S. [Google Scholar] [CrossRef] [PubMed]
  169. Saini, R.K.; Prasad, P.; Lokesh, V.; Shang, X.; Shin, J.; Keum, Y.-S.; Lee, J.-H. Carotenoids: Dietary Sources, Extraction, Encapsulation, Bioavailability, Health Benefits—A Review of Recent Advancements. Antioxidants 2022, 11, 795. [Google Scholar] [CrossRef] [PubMed]
  170. Lee, J.; Jiang, S.; Levine, N.; Watson, R.R. Carotenoid Supplementation Reduces Erythema in Human Skin After Simulated Solar Radiation Exposure. Proc. Soc. Exp. Biol. Med. 2000, 223, 170–174. [Google Scholar]
  171. Stahl, W.; Heinrich, U.; Jungmann, H.; Sies, H.; Tronnier, H. Carotenoids and Carotenoids Plus Vitamin E Protect Against Ultraviolet Light-Induced Erythema in Humans. Am. J. Clin. Nutr. 2000, 71, 795–798. [Google Scholar] [CrossRef] [PubMed]
  172. Heinrich, U.; Gartner, C.; Wiebusch, M.; Eichler, O.; Sies, H.; Tronnier, H.; Stahl, W. Supplementation with Beta-Carotene or a Similar Amount of Mixed Carotenoids Protects Humans from UV-Induced Erythema. J. Nutr. 2003, 133, 98–101. [Google Scholar] [CrossRef]
  173. Gollnick, H.P.M.; Hopfenmüller, W.; Hemmes, C.; Chun, S.C.; Schmid, C.; Sundermeier, K.; Biesalski, H. Systemic Beta Carotene Plus Topical UV-Sunscreen Are an Optimal Protection Against Harmful Effects of Natural UV-Sunlight: Results of the Berlin-Eilat Study. Eur. J. Dermatol. 1996, 6, 200–205. [Google Scholar]
  174. Marini, A.; Jaenicke, T.; Grether-Beck, S.; Le Floch, C.; Cheniti, A.; Piccardi, N.; Krutmann, J. Prevention of Polymorphic Light Eruption by Oral Administration of a Nutritional Supplement Containing Lycopene, ß-Carotene, Lactobacillus johnsonii: Results from a Randomized, Placebo-Controlled, Double-Blinded Study. Photodermatol. Photoimmunol. Photomed. 2014, 30, 189–194. [Google Scholar] [CrossRef]
  175. Davinelli, S.; Nielsen, M.E.; Scapagnini, G. Astaxanthin in Skin Health, Repair, Disease: A Comprehensive Review. Nutrients 2018, 10, 522. [Google Scholar] [CrossRef]
  176. Ng, Q.X.; De Deyn, M.L.Z.Q.; Loke, W.; Foo, N.X.; Chan, H.W.; Yeo, W.S. Effects of Astaxanthin Supplementation on Skin Health: A Systematic Review of Clinical Studies. J. Diet. Suppl. 2021, 18, 169–182. [Google Scholar] [CrossRef]
  177. Roberts, R.L.; Green, J.; Lewis, B. Lutein and Zeaxanthin in Eye and Skin Health. Clin. Dermatol. 2009, 27, 195–201. [Google Scholar] [CrossRef]
  178. Zhou, X.; Cao, Q.; Orfila, C.; Zhao, J.; Zhang, L. Systematic Review and Meta-Analysis on the Effects of Astaxanthin on Human Skin Ageing. Nutrients 2021, 13, 2917. [Google Scholar] [CrossRef] [PubMed]
  179. Schwartz, S.; Frank, E.; Gierhart, D.; Simpson, P.; Frumento, R. Zeaxanthin-Based Dietary Supplement and Topical Serum Improve Hydration and Reduce Wrinkle Count in Female Subjects. J. Cosmet. Dermatol. 2016, 15, 15–20. [Google Scholar] [CrossRef] [PubMed]
  180. Juturu, V.; Bowman, J.P.; Deshpande, J. Overall Skin Tone and Skin-Lightening-Improving Effects with Oral Supplementation of Lutein and Zeaxanthin Isomers: A Double-Blind, Placebo-Controlled Clinical Trial. Clin. Cosmet. Investig. Dermatol. 2016, 9, 325–332. [Google Scholar] [CrossRef]
  181. Ito, N.; Seki, S.; Ueda, F. The Protective Role of Astaxanthin for UV-Induced Skin Deterioration in Healthy People—A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 2018, 10, 817. [Google Scholar] [CrossRef]
  182. Chalyk, N.E.; Klochkov, V.A.; Bandaletova, T.Y.; Kyle, N.H.; Petyaev, I.M. Continuous Astaxanthin Intake Reduces Oxidative Stress and Reverses Age-Related Morphological Changes of Residual Skin Surface Components in Middle-Aged Volunteers. Nutr. Res. 2017, 48, 40–48. [Google Scholar] [CrossRef] [PubMed]
  183. Grether-Beck, S.; Marini, A.; Jaenicke, T.; Stahl, W.; Krutmann, J. Molecular Evidence that Oral Supplementation with Lycopene or Lutein Protects Human Skin Against Ultraviolet Radiation: Results from a Double-Blinded, Placebo-Controlled, Crossover Study. Br. J. Dermatol. 2017, 176, 1231–1240. [Google Scholar] [CrossRef]
  184. Phetcharat, L.; Wongsuphasawat, K.; Winther, K. The Effectiveness of a Standardized Rose Hip Powder, Containing Seeds and Shells of Rosa canina, on Cell Longevity, Skin Wrinkles, Moisture, Elasticity. Clin. Interv. Aging 2015, 10, 1849–1856. [Google Scholar] [PubMed]
  185. Darvin, M.; Patzelt, A.; Gehse, S.; Schanzer, S.; Benderoth, C.; Sterry, W.; Lademann, J. Cutaneous Concentration of Lycopene Correlates Significantly with the Roughness of the Skin. Eur. J. Pharm. Biopharm. 2008, 69, 943–947. [Google Scholar] [CrossRef]
  186. Iravani, S.; Zolfaghari, B. Pharmaceutical and Nutraceutical Effects of Pinus pinaster Bark Extract. Res. Pharm. Sci. 2011, 6, 1–11. [Google Scholar]
  187. Rohdewald, P. A Review of the French Maritime Pine Bark Extract (Pycnogenol), a Herbal Medication with a Diverse Clinical Pharmacology. Int. J. Clin. Pharmacol. Ther. 2002, 40, 158–168. [Google Scholar] [CrossRef] [PubMed]
  188. Chowdhury, W.K.; Arbee, S.; Debnath, S.; Khan, T.A.A.; Afnan, K.; Mahadi, A.S.; Mohib, M.M.; Tisha, A.; Sagor, M.A.T.; Mohiuddin, S. Pycnogenol: A Miracle Component in Reducing Ageing and Skin Disorders. J. Clin. Exp. Dermatol. Res. 2017, 8, 1000395. [Google Scholar] [CrossRef]
  189. Maimoona, A.; Naeem, I.; Saddiqe, Z.; Jameel, K. A Review on Biological, Nutraceutical, Clinical Aspects of French Maritime Pine Bark Extract. J. Ethnopharmacol. 2011, 133, 261–277. [Google Scholar] [CrossRef] [PubMed]
  190. Saliou, C.; Rimbach, G.; Moini, H.; McLaughlin, L.; Hosseini, S.; Lee, J.; Watson, R.R.; Packer, L. Solar Ultraviolet-Induced Erythema in Human Skin and Nuclear Factor-Kappa-B-Dependent Gene Expression in Keratinocytes Are Modulated by a French Maritime Pine Bark Extract. Free Radic. Biol. Med. 2001, 30, 154–160. [Google Scholar] [CrossRef] [PubMed]
  191. Saric, S.; Sivamani, R.K. Polyphenols and Sunburn. Int. J. Mol. Sci. 2016, 17, 1521. [Google Scholar] [CrossRef] [PubMed]
  192. Grether-Beck, S.; Marini, A.; Jaenicke, T.; Krutman, J. French Maritime Pine Bark Extract (Pycnogenol®) Effects on Human Skin: Clinical and Molecular Evidence. Ski. Pharmacol. Physiol. 2016, 29, 13–17. [Google Scholar] [CrossRef]
  193. Michalak, M. Plant-Derived Antioxidants: Significance in Skin Health and the Ageing Process. Int. J. Mol. Sci. 2022, 23, 585. [Google Scholar] [CrossRef]
  194. Păcularu-Burada, B.; Cîrîc, A.I.; Begea, M. Anti-Aging Effects of Flavonoids from Plant Extracts. Foods 2024, 13, 2441. [Google Scholar] [CrossRef]
  195. Jung, H.-Y.; Shin, J.-C.; Park, S.-M.; Kim, N.-R.; Kwak, W.; Choi, B.-H. Pinus densiflora Extract Protects Human Skin Fibroblasts Against UVB-Induced Photoaging by Inhibiting the Expression of MMPs and Increasing Type I Procollagen Expression. Toxicol. Rep. 2014, 1, 658–666. [Google Scholar] [CrossRef]
  196. Blazso, G.; Gabor, M.; Schonlau, F.; Rohdewald, P. Pycnogenol Accelerates Wound Healing and Reduces Scar Formation. Phytother. Res. 2004, 18, 579–581. [Google Scholar] [CrossRef]
  197. Pointner, A.; Magnet, U.; Tomeva, E.; Dum, E.; Bruckmueller, C.; Mayer, C.; Aumueller, E.; Haslberger, A. EGCG Containing Combined Dietary Supplement Affects Telomeres and Epigenetic Regulation. J. Nutr. Food Sci. 2017, 7, 1000577. [Google Scholar] [CrossRef]
  198. Heinrich, U.; Neukam, K.; Tronnier, H.; Sies, H.; Stahl, W. Long-Term Ingestion of High Flavanol Cocoa Provides Photoprotection Against UV-Induced Erythema and Improves Skin Condition in Women. J. Nutr. 2006, 136, 1565–1569. [Google Scholar] [CrossRef] [PubMed]
  199. Marini, A.; Grether-Beck, S.; Jaenicke, T.; Weber, M.; Burki, C.; Formann, P.; Brenden, H.; Schonlau, F.; Krutmann, J. Pycnogenol® Effects on Skin Elasticity and Hydration Coincide with Increased Gene Expressions of Collagen Type I and Hyaluronic Acid Synthase in Women. Ski. Pharmacol. Physiol. 2012, 25, 86–92. [Google Scholar] [CrossRef]
  200. Furumura, M.; Sato, N.; Kusaba, N.; Takagaki, K.; Nakayama, J. Oral Administration of French Maritime Pine Bark Extract (Flavangenol®) Improves Clinical Symptoms in Photoaged Facial Skin. Clin. Interv. Aging 2012, 7, 275–286. [Google Scholar] [CrossRef] [PubMed]
  201. Segger, D.; Schönlau, F. Supplementation with Evelle Improves Skin Smoothness and Elasticity in a Double-Blind, Placebo-Controlled Study with 62 Women. J. Dermatol. Treat. 2004, 15, 222–226. [Google Scholar] [CrossRef]
  202. Buonocore, D.; Lazzeretti, A.; Tocabens, P.; Nobile, V.; Cestone, E.; Santin, G.; Bottone, M.G.; Marzatico, F. Resveratrol-Procyanidin Blend: Nutraceutical and Antiaging Efficacy Evaluated in a Placebo-Controlled, Double-Blind Study. Clin. Cosmet. Investig. Dermatol. 2012, 5, 159–165. [Google Scholar] [CrossRef] [PubMed]
  203. Lopresti, A.L.; Smith, S.J.; Riggs, M.L.; Major, R.A.; Gibb, T.G.; Wood, S.M.; Hester, S.N.; Knaggs, H.E. An Examination into the Effects of a Nutraceutical Supplement on Cognition, Stress, Eye Health, Skin Satisfaction in Adults with Self-Reported Cognitive Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 2024, 16, 1770. [Google Scholar] [CrossRef]
  204. S3-Leitlinie Komplementärmedizin. Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie Hämatologischer und Onkologischer Erkrankungen—Komplementäre und Alternative Therapieverfahren: Aloe Vera. DGHO 2024. Available online: https://redaktion.onkopedia.com/onkopedia/de/onkopedia/archive/guidelines/aloe-vera/version-21032024T103127/@@pdf-latest?filename=aloe-vera-stand-juli-2015.pdf (accessed on 20 February 2025).
  205. Hekmatpou, D.; Mehrabi, F.; Rahzani, K.; Aminiyan, A. The Effect of Aloe Vera Clinical Trials on Prevention and Healing of Skin Wound: A Systematic Review. Iran. J. Med. Sci. 2019, 44, 1–9. [Google Scholar]
  206. Misawa, E.; Tanaka, M.; Saito, M.; Nabeshima, K.; Yao, R.; Yamauchi, K.; Furukawa, F. Protective Effects of Aloe Sterols Against UVB-Induced Photoaging in Hairless Mice. Photodermatol. Photoimmunol. Photomed. 2017, 33, 101–111. [Google Scholar] [CrossRef]
  207. Saito, M.; Tanaka, M.; Misawa, E.; Yao, R.; Nabeshima, K.; Yamauchi, K.; Abe, F.; Yamamoto, Y.; Furukawa, F. Oral Administration of Aloe vera Gel Powder Prevents UVB-Induced Decrease in Skin Elasticity via Suppression of Overexpression of MMPs in Hairless Mice. Biosci. Biotechnol. Biochem. 2016, 80, 1416–1424. [Google Scholar] [CrossRef]
  208. Bałan, B.J.; Niemcewicz, M.; Kocik, J.; Jung, L.; Skopińska-Różewska, E.; Skopiński, P. Oral Administration of Aloe vera Gel, Anti-Microbial and Anti-Inflammatory Herbal Remedy, Stimulates Cell-Mediated Immunity and Antibody Production in a Mouse Model. Cent. Eur. J. Immunol. 2014, 39, 125–130. [Google Scholar] [CrossRef]
  209. Atiba, A.; Nishimura, M.; Kakinuma, S.; Hiraoka, T.; Goryo, M.; Shimada, Y.; Ueno, H.; Uzuka, Y. Aloe vera Oral Administration Accelerates Acute Radiation-Delayed Wound Healing by Stimulating Transforming Growth Factor-β and Fibroblast Growth Factor Production. Am. J. Surg. 2011, 201, 809–818. [Google Scholar] [CrossRef] [PubMed]
  210. Cho, S.; Lee, S.; Lee, M.-J.; Lee, D.H.; Won, C.-H.; Kim, S.M.; Chung, J.H. Dietary Aloe Vera Supplementation Improves Facial Wrinkles and Elasticity and It Increases the Type I Procollagen Gene Expression in Human Skin in vivo. Ann. Dermatol. 2009, 21, 6–11. [Google Scholar] [CrossRef] [PubMed]
  211. Tanaka, M.; Misawa, E.; Yamauchi, K.; Abe, F.; Ishizaki, C. Effects of Plant Sterols Derived from Aloe vera Gel on Human Dermal Fibroblasts in vitro and on Skin Condition in Japanese Women. Clin. Cosmet. Investig. Dermatol. 2015, 8, 95–104. [Google Scholar] [CrossRef]
  212. Kaminaka, C.; Yamamoto, Y.; Sakata, M.; Hamamoto, C.; Misawa, E.; Nabeshima, K.; Saito, M.; Tanaka, M.; Abe, F.; Jinnin, M. Effects of Low-Dose Aloe Sterol Supplementation on Skin Moisture, Collagen Score and Objective or Subjective Symptoms: 12-Week, Double-Blind, Randomized Controlled Trial. J. Dermatol. 2020, 47, 998–1006. [Google Scholar] [CrossRef] [PubMed]
  213. Tanaka, M.; Yamamoto, Y.; Misawa, E.; Nabeshima, K.; Saito, M.; Yamauchi, K.; Abe, F.; Furukawa, F. Effects of Aloe Sterol Supplementation on Skin Elasticity, Hydration, Collagen Score: A 12-Week Double-Blind, Randomized, Controlled Trial. Ski. Pharmacol. Physiol. 2016, 29, 309–317. [Google Scholar] [CrossRef]
  214. Zielińska, A.; Nowak, I. Abundance of Active Ingredients in Sea-Buckthorn Oil. Lipids Health Dis. 2017, 16, 95. [Google Scholar] [CrossRef]
  215. Olas, B. The Beneficial Health Aspects of Sea Buckthorn (Elaeagnus rhamnoides (L.) A. Nelson) Oil. J. Ethnopharmacol. 2018, 213, 183–190. [Google Scholar] [CrossRef]
  216. Wang, K.; Xu, Z.; Liao, X. Bioactive Compounds, Health Benefits and Functional Food Products of Sea Buckthorn: A Review. Crit. Rev. Food Sci. Nutr. 2022, 62, 6761–6782. [Google Scholar] [CrossRef]
  217. Wang, X.; Li, S.; Liu, D.; Kong, J.; Han, X.; Lei, P.; Xu, M.; Guan, H.; Hou, D. Ameliorative Effects of Sea Buckthorn Oil on DNCB Induced Atopic Dermatitis Model Mice via Regulation the Balance of Th1/Th2. BMC Complement. Med. Ther. 2020, 20, 263. [Google Scholar] [CrossRef]
  218. Solà Marsiñach, M.; Cuenca, A.P. The Impact of Sea Buckthorn Oil Fatty Acids on Human Health. Lipids Health Dis. 2019, 18, 145. [Google Scholar] [CrossRef]
  219. Yang, B.; Bonfigli, A.; Pagani, V.; Isohanni, T.; von-Knorring, Å.; Jutila, A.; Judin, V.-P. Effects of Oral Supplementation and Topical Application of Supercritical CO2 Extracted Sea Buckthorn Oil on Skin Aging of Female Subjects. J. Appl. Cosmetol. 2009, 27, 1–13. [Google Scholar]
  220. Chan, L.-P.; Yen, T.-W.; Tseng, Y.-P.; Yuen, T.; Yuen, M.; Yuen, H.; Liang, C.-H. The Impact of Oral Sea-Buckthorn Oil on Skin, Blood Markers, Ocular, Vaginal Health: A Randomized Control Trial. J. Funct. Foods 2024, 112, 105973. [Google Scholar] [CrossRef]
  221. Choudhry, S.Z.; Bhatia, N.; Ceilley, R.; Hougeir, F.; Lieberman, R.; Hamzavi, I.; Lim, H.W. Role of Oral Polypodium leucotomos Extract in Dermatologic Diseases: A Review of the Literature. J. Drugs Dermatol. 2014, 13, 148–153. [Google Scholar] [PubMed]
  222. Rodríguez-Luna, A.; Zamarrón, A.; Juarranz, Á.; González, S. Clinical Applications of Polypodium leucotomos (Fernblock®), An Update. Life 2023, 13, 1513. [Google Scholar] [CrossRef]
  223. Dimitrijevic, J.; Tomovic, M.; Bradic, J.; Petrovic, A.; Jakovljevic, V.; Andjic, M.; Živković, J.; Milošević, S.Đ.; Simanic, I.; Dragicevic, N. Punica granatum L. (Pomegranate) Extracts and Their Effects on Healthy and Diseased Skin. Pharmaceutics 2024, 16, 458. [Google Scholar] [CrossRef]
  224. Wahab, S.; Annadurai, S.; Abullais, S.S.; Das, G.; Ahmad, W.; Ahmad, M.F.; Kandasamy, G.; Vasudevan, R.; Ali, M.S.; Amir, M. Glycyrrhiza glabra (Licorice), A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence, Toxicology. Plants 2021, 10, 2751. [Google Scholar] [CrossRef]
  225. El-Saber Batiha, G.; Magdy Beshbishy, A.; El-Mleeh, A.; Abdel-Daim, M.M.; Prasad Devkota, H. Traditional Uses, Bioactive Chemical Constituents, Pharmacological and Toxicological Activities of Glycyrrhiza glabra L. (Fabaceae). Biomolecules 2020, 10, 352. [Google Scholar] [CrossRef]
  226. Nestor, M.S.; Berman, B.; Swenson, N. Safety and Efficacy of Oral Polypodium leucotomos Extract in Healthy Adult Subjects. J. Clin. Aesthetic Dermatol. 2015, 8, 19–23. [Google Scholar]
  227. Chan, L.P.; Tseng, Y.P.; Liu, C.; Liang, C.H. Fermented Pomegranate Extracts Protect Against Oxidative Stress and Aging of Skin. J. Cosmet. Dermatol. 2022, 21, 2236–2245. [Google Scholar] [CrossRef]
  228. Henning, S.M.; Yang, J.; Lee, R.P.; Huang, J.; Hsu, M.; Thames, G.; Gilbuena, I.; Long, J.; Xu, Y.; Park, E.H.; et al. Pomegranate Juice and Extract Consumption Increases the Resistance to UVB-Induced Erythema and Changes the Skin Microbiome in Healthy Women: A Randomized Controlled Trial. Sci. Rep. 2019, 9, 14528. [Google Scholar] [CrossRef]
  229. Emanuele, E.; Bertona, M.; Biagi, M. Comparative Effects of a Fixed Polypodium leucotomos/Pomegranate Combination Versus Polypodium leucotomos Alone on Skin Biophysical Parameters. Neuro Endocrinol. Lett. 2017, 38, 38–42. [Google Scholar] [PubMed]
  230. Nobile, V.; Dudonné, S.; Kern, C.; Roveda, G.; Garcia, C. Antiaging, Brightening, Antioxidant Efficacy of Fermented Bilberry Extract (Vaccinium myrtillus), A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 2024, 16, 2203. [Google Scholar] [CrossRef]
  231. Zabihi, M.; Hatefi, B.; Ardakani, M.E.; Ranjbar, A.M.; Mohammadi, F. Impact of Licorice Root on the Burn Healing Process: A Double-Blinded Randomized Controlled Clinical Trial. Complement. Ther. Med. 2023, 73, 102941. [Google Scholar] [CrossRef] [PubMed]
  232. Makino, E.T.; Mehta, R.C.; Banga, A.; Jain, P.; Sigler, M.L.L.; Sonti, S. Evaluation of a Hydroquinone-Free Skin Brightening Product Using in Vitro Inhibition of Melanogenesis and Clinical Reduction of Ultraviolet-Induced Hyperpigmentation. J. Drugs Dermatol. 2013, 12, 16–20. [Google Scholar]
  233. Pouchieu, C.; Pourtau, L.; Gaudout, D.; Gille, I.; Chalothorn, K.; Perin, F. Effect of an Oral Formulation on Skin Lightening: Results from in Vitro Tyrosinase Inhibition to a Double-Blind Randomized Placebo-Controlled Clinical Study in Healthy Asian Participants. Cosmetics 2023, 10, 143. [Google Scholar] [CrossRef]
  234. Krasiński, R.; Tchórzewski, H. Hyaluronan-Mediated Regulation of Inflammation. Postepy Hig. Med. Dosw. 2007, 61, 683–689. [Google Scholar] [PubMed]
  235. Balogh, L.; Polyak, A.; Mathe, D.; Kiraly, R.; Thuroczy, J.; Terez, M.; Janoki, G.; Ting, Y.; Bucci, L.R.; Schauss, A.G. Absorption, Uptake and Tissue Affinity of High-Molecular-Weight Hyaluronan After Oral Administration in Rats and Dogs. J. Agric. Food Chem. 2008, 56, 10582–10593. [Google Scholar] [CrossRef]
  236. Göllner, I.; Voss, W.; von Hehn, U.; Kammerer, S. Ingestion of an Oral Hyaluronan Solution Improves Skin Hydration, Wrinkle Reduction, Elasticity, Skin Roughness: Results of a Clinical Study. J. Evid.-Based Complement. Altern. Med. 2017, 22, 816–823. [Google Scholar] [CrossRef]
  237. Kawada, C.; Yoshida, T.; Yoshida, H.; Sakamoto, W.; Odanaka, W.; Sato, T.; Yamasaki, T.; Kanemitsu, T.; Masuda, Y.; Urushibata, O. Ingestion of Hyaluronans (Molecular Weights 800 k and 300 k) Improves Dry Skin Conditions: A Randomized, Double-blind, Controlled Study. J. Clin. Biochem. Nutr. 2015, 56, 66–73. [Google Scholar] [CrossRef]
  238. Michelotti, A.; Cestone, E.; De Ponti, I.; Pisati, M.; Sparta, E.; Tursi, F. Oral Intake of a New Full-Spectrum Hyaluronan Improves Skin Profilometry and Aging: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Eur. J. Dermatol. 2021, 31, 798–805. [Google Scholar] [CrossRef]
  239. Hsu, T.F.; Su, Z.R.; Hsieh, Y.H.; Wang, M.-F.; Oe, M.; Matsuoka, R.; Masuda, Y. Oral Hyaluronan Relieves Wrinkles and Improves Dry Skin: A 12-Week Double-Blinded, Placebo-Controlled Study. Nutrients 2021, 13, 2220. [Google Scholar] [CrossRef] [PubMed]
  240. Oe, M.; Sakai, S.; Yoshida, H.; Okado, N.; Kaneda, H.; Masuda, Y.; Urushibata, O. Oral Hyaluronan Relieves Wrinkles: A Double-Blinded, Placebo-Controlled Study Over a 12-Week Period. Clin. Cosmet. Investig. Dermatol. 2017, 10, 267–273. [Google Scholar] [CrossRef]
  241. Guaitolini, E.; Cavezzi, A.; Cocchi, S.; Colucci, R.; Urso, S.U.; Quinzi, V. Randomized, Placebo-Controlled Study of a Nutraceutical Based on Hyaluronic Acid, L-Carnosine, Methylsulfonylmethane in Facial Skin Aesthetics and Well-Being. J. Clin. Aesthetic Dermatol. 2019, 12, 40–45. [Google Scholar]
  242. Pinnell, S.R. Cutaneous photodamage, oxidative stress, topical antioxidant protection. J. Am. Acad. Dermatol. 2003, 48, 1–19. [Google Scholar] [CrossRef]
  243. Ogawa, Y.; Kawamura, T.; Shimada, S. Zinc and skin biology. Arch. Biochem. Biophys. 2016, 611, 113–119. [Google Scholar] [CrossRef] [PubMed]
  244. Tyszka-Czochara, M.; Słoczyńska, A.; Marciniak, A.; Roszkowski, E.; Bąk, W.; Grodzik, K.; Chojnacka, A.; Król, J.; Pomastowski, P. Zinc and Propolis Reduces Cytotoxicity and Proliferation in Skin Fibroblast Cell Culture: Total Polyphenol Content and Antioxidant Capacity of Propolis. Biol. Trace Elem. Res. 2014, 160, 123–131. [Google Scholar] [CrossRef] [PubMed]
  245. Weismann, K.; Wanscher, B.; Krakauer, R. Oral zinc therapy in geriatric patients with selected skin manifestations and a low plasma zinc level. Acta Derm.-Venereol. 1978, 58, 157–161. [Google Scholar] [CrossRef]
  246. Parat, M.O.; Richard, M.J.; Leccia, M.T.; Amblard, P.; Favier, A.; Beani, J.C. Does manganese protect cultured human skin fibroblasts against oxidative injury by UVA, dithranol and hydrogen peroxide? Free. Radic. Res. 1995, 23, 339–351. [Google Scholar] [CrossRef]
  247. Goluch, Z.; Haraf, G. Goose Meat as a Source of Dietary Manganese—A Systematic Review. Animals 2023, 13, 840. [Google Scholar] [CrossRef]
  248. Egoumenides, L.; Gauthier, A.; Barial, S.; Saby, M.; Orechenkoff, C.; Simoneau, G.; Carillon, J. A Specific Melon Concentrate Exhibits Photoprotective Effects from Antioxidant Activity in Healthy Adults. Nutrients 2018, 10, 437. [Google Scholar] [CrossRef]
  249. Gad, M. Anti-aging effects of L-arginine. J. Adv. Res. 2010, 1, 169–177. [Google Scholar] [CrossRef]
  250. OyetakinWhite, P.; Tribout, H.; Baron, E. Protective mechanisms of green tea polyphenols in skin. Oxidative Med. Cell. Longev. 2012, 2012, 560682. [Google Scholar] [CrossRef] [PubMed]
  251. Sekhar, R.V.; Patel, S.G.; Guthikonda, A.P.; Reid, M.; Balasubramanyam, A.; Taffet, G.E.; Jahoor, F. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am. J. Clin. Nutr. 2011, 94, 847–853. [Google Scholar] [CrossRef]
  252. Takaoka, M.; Okumura, S.; Seki, T.; Ohtani, M. Effect of amino acid intake on physical conditions and skin state: A randomized, double-blind, placebo-controlled, crossover trial. J. Clin. Biochem. Nutr. 2019, 65, 52–58. [Google Scholar] [CrossRef] [PubMed]
  253. Farrar, M.D.; Nicolaou, A.; Clarke, K.A.; Mason, S.; Massey, K.A.; Dew, T.P.; Watson, R.E.B.; Williamson, G.; Rhodes, L.E. A randomized controlled trial of green tea catechins in protection against ultraviolet radiation–induced cutaneous inflammation. Am. J. Clin. Nutr. 2015, 102, 608–615. [Google Scholar] [CrossRef]
  254. Costa, A.; Pereira, E.S.P.; Assumpcao, E.C.; Calixto Dos Santos, F.B.; Ota, F.S.; de Oliveira Pereira, M.; Fidelis, M.C.; Favaro, R.; Barros Langen, S.S.; Favaro de Arruda, L.H. Assessment of clinical effects and safety of an oral supplement based on marine protein, vitamin C, grape seed extract, zinc, tomato extract in the improvement of visible signs of skin ageing in men. Clin. Cosmet. Investig. Dermatol. 2015, 8, 319–328. [Google Scholar] [CrossRef]
  255. Costa, A.; Lindmark, L.; Arruda, L.H.F.; Assumpção, E.C.; Ota, F.S.; de Oliveira Pereira, M.; Langen, S.S.B. Clinical, biometric and ultrasound assessment of the effects of daily use of a nutraceutical composed of lycopene, acerola extract, grape seed extract, Biomarine Complex in photoaged human skin. An. Bras. Dermatol. 2012, 87, 52–61. [Google Scholar] [CrossRef]
  256. Costa, A.; Pereira, E.S.P.; Fávaro, R.; de Oliveira Pereira, M.; Stocco, P.L.; Assumpção, E.C.; Ota, F.S.; Langen, S.S.B. Treating cutaneous photoaging in women with an oral supplement based on marine protein, concentrated acerola, grape seed extract, tomato extract, for 360 days. Surg. Cosmet. Dermatol. 2011, 3, 302–311. [Google Scholar]
  257. Dumoulin, M.; Gaudout, D.; Lemaire, B. Clinical effects of an oral supplement rich in antioxidants on skin radiance in women. Clin. Cosmet. Investig. Dermatol. 2016, 9, 315–324. [Google Scholar] [CrossRef]
  258. Grether-Beck, S.; Marini, A.; Jaenicke, T.; Krutmann, J. Effective photoprotection of human skin against infrared A radiation by topically applied antioxidants: Results from a vehicle-controlled, double-blind, randomized study. Photochem. Photobiol. 2015, 91, 248–250. [Google Scholar] [CrossRef]
  259. Pérez-Sanchez, A.; Barrajon-Catalan, E.; Caturla, N.; Castillo, J.; Benavente-Garcia, O.; Alcaraz, M.; Micol, V. Protective effects of citrus and rosemary extracts on UV-induced damage in skin cell model and human volunteers. J. Photochem. Photobiol. B. 2014, 136, 12–18. [Google Scholar] [CrossRef] [PubMed]
  260. Nobile, V.; Michelotti, A.; Cestone, E.; Caturla, N.; Castillo, J.; Benavente-Garcia, O.; Pérez-Sanchez, A.; Micol, V. Skin photoprotective and anti-aging effects of a combination of rosemary (Rosmarinus officinalis) and grapefruit (Citrus paradisi) polyphenols. Food. Nutr. Res. 2016, 60, 31871. [Google Scholar] [CrossRef] [PubMed]
  261. Puglia, C.; Offerta, A.; Saija, A.; Trombetta, D.; Venera, C. Protective effect of red orange extract supplementation against UV-induced skin damages: Photoaging and solar lentigines. J. Cosmet. Dermatol. 2014, 13, 151–157. [Google Scholar] [CrossRef] [PubMed]
  262. Belwal, T.; Devkota, H.P.; Hassan, H.A.; Ahluwalia, S.; Ramadan, M.F.; Mocan, A.; Atanasov, A.G. Phytopharmacology of Acerola (Malpighia spp.) and its potential as functional food. Trends Food Sci. Technol. 2018, 74, 99–106. [Google Scholar] [CrossRef]
  263. Sato, Y.; Uchida, E.; Aoki, H.; Hanamura, T.; Nagamine, K.; Kato, H.; Koizumi, T.; Ishigami, A. Acerola (Malpighia emarginata DC.) Juice Intake Suppresses UVB-Induced Skin Pigmentation in SMP30/GNL Knockout Hairless Mice. PLoS ONE 2017, 12, e0170438. [Google Scholar] [CrossRef]
  264. Uchida, E.; Sato, Y.; Kondo, N.; Aoki, H.; Yonei, T.; Yoshikawa, A.; Takahara, S.; Iwama, Y.; Ishigami, T.; Kondo, K. Absorption and Excretion of Ascorbic Acid Alone and in Acerola (Malpighia emarginata) Juice: Comparison in Healthy Japanese Subjects. Biol. Pharm. Bull. 2011, 34, 1744–1747. [Google Scholar] [CrossRef]
  265. Guéniche, A.; Bastien, P.; Ovigne, J.M.; Kermici, M.; Courchay, G.; Chevalier, V.; Breton, L.; Castiel-Higounenc, I. Bifidobacterium longum lysate, a New Ingredient for Reactive Skin. Exp. Dermatol. 2010, 19, e1–e8. [Google Scholar] [CrossRef]
  266. Da Costa Baptista, I.P.; Accioly, E.; de Carvalho Padilha, P. Effect of the Use of Probiotics in the Treatment of Children with Atopic Dermatitis: A Literature Review. Nutr. Hosp. 2013, 28, 16–26. [Google Scholar]
  267. Smith-Norowitz, T.A.; Bluth, M.H. Probiotics and Diseases of Altered IgE Regulation: A Short Review. J. Immunotoxicol. 2016, 13, 136–140. [Google Scholar] [CrossRef]
  268. Chang, Y.-S.; Trivedi, M.K.; Jha, A.; Lin, Y.-F.; Dimaano, L.; García-Romero, M.T. Synbiotics for Prevention and Treatment of Atopic Dermatitis: A Meta-Analysis of Randomized Controlled Clinical Trials. JAMA Pediatr. 2016, 170, 236–242. [Google Scholar] [CrossRef]
  269. Probiotika: Doch Nicht Nützlich? Cell Press. 07.09. 218—DAL. 2018. Available online: https://www.scinexx.de/news/medizin/probiotika-doch-nicht-nuetzlich/ (accessed on 20 February 2025).
  270. Gao, T.; Wang, X.; Li, Y.; Ren, F. The Role of Probiotics in Skin Health and Related Gut-Skin Axis: A Review. Nutrients 2023, 15, 3123. [Google Scholar] [CrossRef] [PubMed]
  271. Im, A.R.; Lee, B.; Kang, D.J.; Chae, S. Skin Moisturizing and Antiphotodamage Effects of Tyndallized Lactobacillus acidophilus IDCC 3302. J. Med. Food 2018, 21, 1016–1023. [Google Scholar] [CrossRef] [PubMed]
  272. Kim, H.; Kim, H.R.; Jeong, B.J.; Lee, S.S.; Kim, T.R.; Jeong, J.H.; Lee, M.; Lee, S.; Lee, J.S.; Chung, D.K. Effects of Oral Intake of Kimchi-Derived Lactobacillus plantarum K8 Lysates on Skin Moisturizing. J. Microbiol. Biotechnol. 2015, 25, 74–80. [Google Scholar] [CrossRef] [PubMed]
  273. Braegger, C.P. Prebiotika. Paediatrica 2004, 15, 20–21. [Google Scholar]
  274. Hong, Y.H.; Chang, U.J.; Kim, Y.S.; Jung, E.Y.; Suh, H.J. Dietary Galacto-Oligosaccharides Improve Skin Health: A Randomized Double-blind Clinical Trial. Asia Pac. J. Clin. Nutr. 2017, 26, 613–618. [Google Scholar]
  275. Miyazaki, K.; Masuoka, N.; Kano, M.; Iizuka, R. Bifidobacterium Fermented Milk and Galacto-Oligosaccharides Lead to Improved Skin Health by Decreasing Phenols Production by Gut Microbiota. Benef. Microbes 2014, 5, 121–128. [Google Scholar] [CrossRef]
  276. Kano, M.; Masuoka, N.; Kaga, C.; Sugimoto, S.; Iizuka, R.; Manabe, K.; Sone, T.; Oeda, K.; Nonaka, C.; Miyazaki, K.; et al. Consecutive Intake of Fermented Milk Containing Bifidobacterium breve Strain Yakult and Galactooligosaccharides Benefits Skin Condition in Healthy Adult Women. Biosci. Microbiota Food Health 2013, 32, 33–39. [Google Scholar] [CrossRef]
  277. Marcheggiani, F.; Cirilli, I.; Orlando, P.; Silvestri, S.; Vogelsang, A.; Knott, A.; Blatt, T.; Weise, J.M.; Tiano, L. Modulation of Coenzyme Q10 content and oxidative status in human dermal fibroblasts using HMG-CoA reductase inhibitor over a broad range of concentrations. From mitohormesis to mitochondrial dysfunction and accelerated aging. Aging 2019, 11, 2565–2582. [Google Scholar] [CrossRef]
  278. Prahl, S.; Kueper, A.; Buesing, K.; Rudolf, G.; Schroeder, P. Aging skin is functionally anaerobic: Importance of coenzyme Q10 for anti-aging skin care. Biofactors 2008, 32, 245–255. [Google Scholar] [CrossRef]
  279. Zmitek, K.; Pogacnik, T.; Mervic, L.; Zmitek, J.; Pravst, I. The effect of dietary intake of coenzyme Q10 on skin parameters and condition: Results of a randomized, placebo-controlled, double-blind study. Biofactors 2017, 43, 132–140. [Google Scholar] [CrossRef]
  280. Smit, N.; Vicanova, J.; Pavel, S. The Hunt for Natural Skin Whitening Agents. Int. J. Mol. Sci. 2009, 10, 5326–5349. [Google Scholar] [CrossRef] [PubMed]
  281. EFSA. Scientific Opinion on the substantiation of health claims related to niacin and reduction of tiredness and fatigue (ID 47), contribution to normal energy-yielding metabolism (ID 51), contribution to normal psychological functions (ID 55), maintenance of normal blood flow (ID 211), maintenance of normal skin and mucous membranes (ID 4700) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J. 2006, 8, 1757. [Google Scholar] [CrossRef]
  282. Hanna, M.; Jaqua, E.; Nguyen, V.; Clay, J. B Vitamins: Functions and Uses in Medicine. Perm. J. 2022, 26, 89–97. [Google Scholar] [CrossRef] [PubMed]
  283. Niren, N.M. Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: A review. Cutis 2006, 77, 11–16. [Google Scholar]
  284. Morrow, J.D.; Hanson, K.E.; Isakson, P.C.; Razack, R.A.; Roberts, F.J. Identification of Skin as a Major Site of Prostaglandin D2 Release Following Oral Administration of Niacin in Humans. J. Investig. Dermatol. 1992, 98, 812–815. [Google Scholar] [CrossRef]
  285. Hoffmann, M.R.; Senior, P.A.; Mager, D.R. Vitamin D supplementation and health-related quality of life: A systematic review of the literature. J. Acad. Nutr. Diet. 2015, 115, 406–418. [Google Scholar] [CrossRef]
  286. Navarro-Triviño, F.J.; Arias-Santiago, S.; Gilaberte-Calzada, Y. Vitamin D and the Skin: A Review for Dermatologists. Actas Dermo-Sifiliográficas 2019, 110, 262–272. [Google Scholar] [CrossRef]
  287. Bocheva, G.; Slominski, R.M.; Slominski, A.T. The Impact of Vitamin D on Skin Aging. Int. J. Mol. Sci. 2021, 22, 9097. [Google Scholar] [CrossRef]
  288. Bouillon, R.; Manousaki, D.; Rosen, C.; Trajanoska, K.; Rivadeneira, F.; Richards, J.B. The health effects of vitamin D supplementation: Evidence from human studies. Nat. Rev. Endocrinol. 2022, 18, 96–110. [Google Scholar] [CrossRef]
  289. Mohamed, A.A.; Hussein, M.S.; Salah, E.M.; Eldemery, A.; Darwish, M.M.; Ghaith, D.M.; Attala, R.A.; El Borolossy, R. Efficacy and safety of active vitamin D supplementation in chronic spontaneous urticaria patients. J. Dermatol. Treat. 2022, 33, 427–432. [Google Scholar] [CrossRef]
  290. Yeowell, H.N.; Marshall, M.K.; Walker, L.C.; Ha, V.; Pinnell, S.R. Regulation of lysyl oxidase mRNA in dermal fibroblasts from normal donors and patients with inherited connective tissue disorders. Arch. Biochem. Biophys. 1994, 308, 299–305. [Google Scholar] [CrossRef] [PubMed]
  291. Kanteev, M.; Goldfeder, M.; Fishman, A. Structure-function correlations in tyrosinases. Protein Sci. 2015, 24, 1360–1369. [Google Scholar] [CrossRef] [PubMed]
  292. Driscoll, M.S.; Kwon, E.K.; Skupsky, H.; Kwon, S.Y.; Grant-Kels, J.M. Nutrition and the deleterious side effects of nutritional supplements. Clin. Dermatol. 2010, 28, 371–379. [Google Scholar] [CrossRef]
  293. Borkow, G. Using Copper to Improve the Well-Being of the Skin. Curr. Chem. Biol. 2014, 8, 89–102. [Google Scholar] [CrossRef]
  294. Pickart, L.; Margolina, A. Skin Regenerative and Anti-Cancer Actions of Copper Peptides. Cosmetics 2018, 5, 29. [Google Scholar] [CrossRef]
  295. Rayman, M.P. Selenium and human health. Lancet 2012, 379, 1256–1268. [Google Scholar] [CrossRef] [PubMed]
  296. Hazane-Puch, F.; Champelovier, P.; Arnaud, J.; Trocmé, C.; Garrel, C.; Faure, P.; Laporte, F. Six-day selenium supplementation led to either UVA-photoprotection or toxic effects in human fibroblasts depending on the chemical form and dose of Se. Metallomics 2014, 6, 1683–1692. [Google Scholar] [CrossRef]
  297. Krausz, A.; Gunn, H.; Friedman, A. The basic science of natural ingredients. J. Drugs. Dermatol. 2014, 13, 937–943. [Google Scholar]
  298. Perrone, D.; Ardito, A.; Pucci, F.; Aiello, A.; Russo, M.; Trapasso, N.; Garufi, C.; Buongiorno-Nardelli, S. Biological and therapeutic activities, anticancer properties of curcumin (Review). Exp. Ther. Med. 2015, 10, 1615–1623. [Google Scholar] [CrossRef]
  299. Nguyen, T.A.; Friedman, A.J. Curcumin: A novel treatment for skin-related disorders. J. Drugs. Dermatol. 2013, 12, 1131–1137. [Google Scholar]
  300. Gustav Parmentier GmbH. Phytosterols and Phytosterol Esters in Nutrition and Cosmetics. Phytosterols Brochure. 2014. Available online: http://www.parmentier.de/gpfneu/Sterol_Esters.pdf (accessed on 20 February 2025).
  301. Bundesinstitut für Risikobewertung. Lebensmittel mit Pflanzensterol- und Pflanzenstanol-Zusatz: Bewertung einer Neuen Studie aus den Niederlanden. Statement 2013, 006/2012 from the BfR on December 01 2011, Supplemented on January 21, 2013. Available online: https://mobil.bfr.bund.de/cm/343/lebensmittel-mit-pflanzensterol-und-pflanzenstanol-zusatz-bewertung-einer-neuen-studie-aus-den-niederlanden.pdf (accessed on 20 February 2025).
  302. Bundesinstitut für Risikobewertung. Menschen mit Normalen Cholesterinwerten Sollten auf den Verzehr von Lebensmitteln mit Zugesetzten Pflanzensterinen Verzichten. Statement 2008, 042/2008 from the BfR on September 03 2008. Available online: https://mobil.bfr.bund.de/cm/343/menschen_mit_normalen_cholesterinwerten.pdf (accessed on 20 February 2025).
  303. Lolou, V.; Panayiotidis, M.I. Functional Role of Probiotics and Prebiotics on Skin Health and Disease. Fermentation 2019, 5, 41. [Google Scholar] [CrossRef]
  304. Maguire, M.; Maguire, G. The role of microbiota, probiotics and prebiotics in skin health. Arch. Dermatol. Res. 2017, 309, 411–421. [Google Scholar] [CrossRef]
  305. Al-Ghazzewi, F.H.; Tester, R.F. Impact of prebiotics and probiotics on skin health. Benef. Microbes 2014, 5, 99–107. [Google Scholar] [CrossRef] [PubMed]
  306. Agbabiaka, T.B.; Pittler, M.H.; Wider, B.; Ernst, E. Serenoa repens (saw palmetto), a systematic review of adverse events. Drug Saf. 2009, 32, 637–647. [Google Scholar] [CrossRef]
  307. Rossi, A.; Mari, E.; Scarno, M.; Garelli, V.; Maxia, C.; Scali, E.; Iorio, A.; Carlesimo, M. Comparative effectiveness of finasteride vs serenoa repens in male androgenetic alopecia: A two-year study. Int. J. Immunopathol. Pharmacol. 2012, 25, 1167–1173. [Google Scholar] [CrossRef]
  308. Kang, S.; Chung, J.H.; Lee, J.H.; Fisher, G.J.; Wan, Y.S.; Duell, E.A.; Voorhees, J.J. Topical N-acetyl cysteine and genistein prevent ultraviolet-light-induced signalling that lead to photoaging in human skin in vivo. J. Investig. Dermatol. 2003, 120, 835–841. [Google Scholar] [CrossRef]
  309. Cassidy, P.B.; Liu, T.; Florell, S.R.; Honeggar, M.; Leachman, S.A.; Boucher, K.M.; Grossman, D. A phase II randomized placebo-controlled trial of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress in vivo. Cancer Prev. Res. 2017, 10, 36–44. [Google Scholar] [CrossRef]
  310. Nakai, K.; Yoneda, K.; Murakami, Y.; Koura, A.; Maeda, R.; Tamai, A.; Ishikawa, E.; Yokoi, I.; Moriue, J.; Moriue, T.; et al. Effects of Topical N-Acetylcysteine on Skin Hydration/Transepidermal Water Loss in Healthy Volunteers and Atopic Dermatitis Patients. Ann. Dermatol. 2015, 27, 450–451. [Google Scholar] [CrossRef] [PubMed]
  311. Lassus, A.; Jeskanen, L.; Happonen, H.P.; Santalahti, J. Imedeen for the treatment of degenerated skin in females. J. Int. Med. Res. 1991, 19, 147–152. [Google Scholar] [CrossRef]
  312. Kieffer, M.E.; Efsen, J. Imedeen in the treatment of photoaged skin: An efficacy and safety trial over 12 months. J. Eur. Acad. Dermatol. Venereol. 1998, 11, 129–136. [Google Scholar] [CrossRef]
  313. Birnbaum, J.E.; Zugerman, M.E.; Fowler, J.L.; Krathen, C.G.; Mettinger, M.P.; Grindel, B.A.; Tanghetti, E.; Aschoff, S.; Perez, C.O.; Leyden, J.J. A multicenter, placebo-controlled, double-blind clinical trial assessing the effects of a multicomponent nutritional supplement for treating photoaged skin in healthy women. J. Cosmet. Dermatol. 2016, 16, 120–131. [Google Scholar] [CrossRef]
  314. Eskelinen, A.; Santalahti, J. Natural cartilage polysaccharides for the treatment of sun-damaged skin in females: A double-blind comparison of vivida and imedeen. J. Int. Med. Res. 1992, 20, 227–233. [Google Scholar] [CrossRef]
  315. Skovgaard, G.R.; Jensen, A.S.; Sigler, M.L. Effect of a novel dietary supplement on skin aging in post-menopausal women. Eur. J. Clin. Nutr. 2006, 60, 1201–1206. [Google Scholar] [CrossRef] [PubMed]
  316. Stephens, T.J.; Sigler, M.L.; Hino, P.D.; Moigne, A.L.; Dispensa, L. A randomized, double-blind, placebo-controlled clinical trial evaluating an oral anti-aging skin care supplement for treating photo-damaged skin. J. Clin. Aesthet. Dermatol. 2016, 9, 25–32. [Google Scholar] [PubMed]
  317. Gibson, G.R.; Roberfroid, M.B. Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics. J. Nutr. 1995, 125, 1401–1412. [Google Scholar] [CrossRef]
  318. Omenn, G.S.; Goodman, G.E.; Thornquist, M.D.; Balmes, J.; Cullen, M.R.; Glass, A.; Keogh, J.P.; Meyskens, F.L.; Valanis, B.; Williams, J.H.; et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 1996, 334, 1150–1155. [Google Scholar] [CrossRef]
  319. Duda-Chodak, A.; Tarko, T. Possible Side Effects of Polyphenols and Their Interactions with Medicines. Molecules 2023, 28, 2536. [Google Scholar] [CrossRef]
  320. Bundesinstitut für Risikobewertung. Die Einnahme von Nicotinsäure in überhöhter Dosierung Kann die Gesundheit Schädigen. Statement 2012, 018/2012 from the BfR on February 06 2012. Available online: https://mobil.bfr.bund.de/cm/343/die-einnahme-von-nicotinsaeure-in-ueberhoehter-dosierung-kann-die-gesundheit-schaedigen.pdf (accessed on 20 February 2025).
  321. Danby, F.W. Nutrition and aging skin: Sugar and glycation. Clin. Dermatol. 2010, 28, 409–411. [Google Scholar] [CrossRef]
Table 2. Simplified Classification of Evidence.
Table 2. Simplified Classification of Evidence.
Level IActive ingredients with proven efficacy in vivo
Level IaEfficacy proven in placebo-controlled double-blind studies (PCDB studies)
Level IbEfficacy proven in other studies conducted with objectifiable methods (RCT or similar, no PCDB studies)
Level IIActive ingredients with proven efficacy in vitro
Level IIIOther advertised active ingredients
Table 3. Categorization of nutraceuticals with supporting references: GROUP 1—ingredients with proven efficacy (clinical studies).
Table 3. Categorization of nutraceuticals with supporting references: GROUP 1—ingredients with proven efficacy (clinical studies).
Nutraceutical/IngredientReviewsPre-Clinical DataClinical DataRCT
Substance-Related
RCT in CombinationOtherEvidence *Comments
VitaminsVitamin A HC[1,10,13,16,38,39,40,41,42,43,44,45,46][47,48] [49,50][51] Ia 1see β-carotene
Biotin HC (Vitamin B7 or Vitamin H)[13,38,40,43,52,53,54,55][56][57] [58] Ia 2EFSA Health Claims, numerous reviews, one PCDB in combination, objectively measurable animal studies, (older) human studies, and studies on hair effects. Higher dosages: Medical product or drug
Vitamin C HC[1,3,4,7,8,10,13,14,16,32,38,40,43,46,59,60,61][62][63,64][65][66,67,68] IaFew substance-related PCDB, but undeniable skin effects. EFSA Health Claim, efficacy enhancement in combination with vitamin E.
Vitamin E[3,4,8,10,13,14,16,38,40,43,46,58,59,69,70][71][63] [67,68]Many topical studiesIb 2PCDB evidence of effectiveness only demonstrated in combination with vitamin C but supported by many other objectively measurable data. Studies required to determine the dose needed for maximum skin improvement.
Fatty acids, LipidsOmega-3 fatty acids (PUFA)[1,2,3,4,7,13,16,43,72,73][74,75,76,77][63,78,79,80,81][82][83] IaNumerous studies on various omega-3 fatty acids, often not involving the same substance but rather different PUFAs or fish or evening primrose oil.
Ceramides[4,10,12,84,85,86][87][88,89][90][91,92] IaSeveral PCDB, preclinical investigations, and coherent reviews.
Collagen PeptidesCollagen peptides from cattle or pigs[2,4,8,10,12,16,40,93,94,95,96,97,98,99,100,101,102,103,104,105] [106,107,108,109,110,111,112,113,114,115,116,117][118,119,120,121,122,123,124,125,126,127,128][129,130,131,132,133,134,135,136,137,138] [139,140,141,142,143,144,145,146,147][148] Ia 1A large number of studies and meta-analyses, numerous double-blind RCTs, various collagen peptides (from pigs or cattle, e.g., Verisol®, Peptan®) with well-documented, product-specific PCDB, some combined with other nutrients (e.g., ELASTEN®). Verisol is also known as a component of various combination products.
Marine/fish collagen peptides[149,150,151,152][153] [154,155,156,157][158] Ia(Marine) collagen peptides from fish, many studies, including substance-related PCDB.
Chicken collagen peptides[159][108,160,161] [162,163][164,165]Ia 2Not yet as well documented as other collagen peptides, but two PCDB with extracts and preclinical studies. Additional PCDB needed for effects on joints.
Collagen-like peptides from non-animal sources [166] Ia(Few) data available, one PCDB.
Carotenoidsß-carotene[3,4,7,10,12,14,16,167,168,169] [170,171,172][173][174] IaPrecursor for vitamin A, for which there are undeniable effects and an EFSA Health Claim. PCDB available. Further studies required to determine dosing and possible health risks; increased risk of lung cancer is discussed.
Lutein, zeaxanthin, astaxanthin[3,4,8,13,175,176,177,178] [179][180,181,182,183][184] IaClinical evidence of skin improvement, particularly for astaxanthin (PCDB), meta-analysis.
Lycopene[2,3,16] [185][183][174] IaOne substance-related PCDB, otherwise unconvincing studies; studies needed to determine the optimal dose.
Plant and animal substances/extractsPolyphenols: Pinus extract (maritime pine bark extract), flavonoids, resveratrol[7,10,12,186,187,188,189,190,191,192,193,194][195,196][197,198,199,200] [158,201,202,203] Ia 2Studies partially with topical application or combination products, but alongside one PCDB in combination, many other objectively measurable studies. Bioavailability in humans remains an unresolved issue.
Aloe vera gel[2,3,12,204,205] [206,207,208,209][210][211,212][213] IaSubstance-related PCDB. Studies required to determine the optimal daily dose and possible health risks; studies also show effects with topical application of the extract.
Sea buckthorn oil[214,215,216][217][218,219][220] IbNumerous indications, some studies, currently one RCT evidence.
Other extracts: Polypodium leucotomos, pomegranate, bilberry extract, liquorice root extract[221,222,223,224,225] [226,227,228,229,230,231][232,233] IaSubstance-related PCDB.
Hyaluronic acid[12,214,234][235][236][237,238,239,240][241] Ia 1Several PCDB and a meta-analysis, but some weak effects and critical assessments. Extensive evidence in the literature.
HC EFSA Health Claim related to the skin is available; * Based on the classification scheme in Table 2; 1 Already evaluated as a dermocosmetic by the Society for Dermopharmacy (GD); 2 RCT not substance-related, in another area of application or in combination.
Table 4. Categorization of nutraceuticals with supporting references: GROUP 2—ingredients with less well-documented efficacy.
Table 4. Categorization of nutraceuticals with supporting references: GROUP 2—ingredients with less well-documented efficacy.
Nutraceutical/IngredientReviewsPre-Clinical DataClinical DataRCT
Substance-Related
RCT in CombinationOtherEvidence *Comments
Minerals/trace elementsZinc HC[3,4,55,242,243][244][245] IIUndisputed skin effects, EFSA Health Claim. But RCTs and studies to determine the dose required for maximum skin improvement are lacking.
Manganese HC[246,247] [248] II 2One RCT with a manganese-containing bitter melon extract shows strong photoprotective effects. EFSA Health Claim, but few literature data.
Amino acidsL-arginine,
L-glutamine,
L-leucine, etc.
[249][250][251] [252] Importance for the skin is undisputed, but no RCT or no substance-related clinical studies and only a few published data.
Secondary natural productsPolyphenols: Catechins from green tea extract, grape seed/skin extract[7,8,10,12,14] [253,254,255,256,257][258]II 1No significant results with catechins from green tea (GTC), probably due to underdosing of the GTC; Pinus extract, flavanol-rich cocoa: see herbal and animal substances/extracts. Grape extracts: studies currently only in combination or topical.
Plant ExtractsCitrus/rosemary extracts[259] [260,261] IINo RCT, or clinical studies only in combination and without placebo; additional studies required to verify the previous results.
Acerola extract[262][263][264] IINo RCT so far, positive effects rather in combination with other substances. Advantageous: High endogenous vitamin C content.
Probiotics and prebioticsProbiotics (Lactobacillus, Bifido-bacterium)[2,7,8,12,15,265,266,267,268,269,270][271,272][272] IIMany studies in children and/or with topical application; beneficial effects for the skin despite divergent study quality and data often described, but only one RCT.
Galacto-oligo-saccharides[2,7,273] [274] [275,276] II 2The available studies (in combination with bifidobacteria) suggest a significant improvement in skin properties (hydration and skin barrier function). Few literature references.
OtherCoenzym Q10[3,4,7,8][277][278][279] IIUndisputed skin effects, EFSA Health Claim. But RCTs and studies to determine the dose required for maximum skin improvement are lacking.
HC EFSA Health Claim related to the skin is available; * Based on the classification scheme in Table 2; 1 Already evaluated as a dermocosmetic by the Society for Dermopharmacy (GD); 2 RCT not substance-related, in another area of application or in combination.
Table 5. Categorization of nutraceuticals with supporting references: GROUP 3—ingredients with insufficiently documented effects.
Table 5. Categorization of nutraceuticals with supporting references: GROUP 3—ingredients with insufficiently documented effects.
Nutraceutical/IngredientReviewsPre-Clinical DataClinical DataRCT
Substance-Related
RCT in CombinationOtherEvidence *Comments
VitaminsVitamins B1, B2 HC, B3 HC,
B5, B6
[1,10,280,281,282,283] [284] IIINo conclusive clinical evidence so far, one RCT without significant results. EFSA Health Claims for B2 and B3.
Vitamin D[285,286,287,288] [289] IIIFew, mostly very old or unsuitable studies with limited data and findings
Minerals/trace elementsCopper HC[3,290,291,292,293,294] IIIInsufficient clinical studies. EFSA Health Claim.
Selenium HC[3,4,295][296] IIIRCTs and studies to determine the necessary dose are lacking, transition metal, higher doses are harmful (oxidative stress), EFSA Health Claims for connective tissue, skin and hair pigmentation.
Sec. natural
products
Curcumin[12,13,297,298,299] IIIReviews, but no studies, EFSA Health Claims on hair and nails
Plant and
animal substances
Phytosterols (except Aloe sterols)[4,300,301,302] IIINo suitable studies to prove skin effects
Polysaccharides[4,303,304,305] IIINo study so far to prove positive skin effects with oral application
Serenoa repens[3,306] [307] IIIOnly studies with multi-combination preparations; conclusions on individual substances problematic.
Pre-bioticsOther prebiotics[2,15,303,304,305] IIINo sufficient evidence so far; existing studies with focus on hair loss
OtherN-acetylcysteine)[3][308][250] [309] [310]IIINo scientific evidence/studies
HC EFSA Health Claim related to the skin is available; * Based on the classification scheme in Table 2.
Table 6. Combinations of Ingredients in dietary supplements with supporting references.
Table 6. Combinations of Ingredients in dietary supplements with supporting references.
Nutraceutical/IngredientExamplesReviewProduct-Related ProofEvidence *Comments
ClinicalRCT
Bovine or porcine collagen peptides, vitamins, and othersELASTEN®[12,93,99,100,101,104][118,119,120,122,123][141,142] IaVery well-documented, product-specific RCTs, meta-analyses, also visualization of the collagen network before/after using scanning electron microscopy
Doppelherz® system KOLLAGEN BEAUTY [144]IaOne product-specific PCDB study
Pure Gold Collagen®[40,100][124][139,140]IaProduct-specific studies, including 1 PCDB study
Fish collagen, Pinus, vitamins, carotenoids and othersFish-derived collagen peptide (FUJIFILM)[12,100] [145]IaOne product-specific PCDB study
Evelle® [201,202]IaSeveral product-specific PCDB studies
Vinh Wellness Collagen [154]IaOne product-specific PCDB
Cellergen® (Switzerland) [158]IbOne single-blind RCT
Proteins, polysaccharides, vitamins, and othersImedeen®[254,311][312] [313,314,315,316]IaWell-documented, several product-specific PCDB studies
Vivida® [313] One product-specific study
Hyaluronic acid, plant concentrates, biotin, vitamins, and othersRegulat-pro® Hyaluron [236][239]IaSeveral studies, including 1 PCDB study
Amino acids, vitamins, mineralsFermented papaya fruit extract (Carica papaya L.) [64]IbProduct-specific double-blind study vs. active control (antioxidants), but not against placebo
Citrus extract, rosemary extractNutroxsun® [260]IbOne RCT on UVA and UVB protection
Licorice root extract, grape seed extract, grape pomace extract, vitamin CBelight2®, SkinMedica® [232,233]IbTwo product-specific RCTs on skin lightening
Various vitamins, zinc, niacin, biotinVitamin Haut&Haare (and many more in varying compositions)[55] IIINo significant studies available to date
* Based on the classification scheme in Table 2.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Streker, M.; Proksch, E.; Kattenstroth, J.-C.; Poeggeler, B.; Lemmnitz, G. Comparative Assessment of Nutraceuticals for Supporting Skin Health. Nutraceuticals 2025, 5, 13. https://doi.org/10.3390/nutraceuticals5020013

AMA Style

Streker M, Proksch E, Kattenstroth J-C, Poeggeler B, Lemmnitz G. Comparative Assessment of Nutraceuticals for Supporting Skin Health. Nutraceuticals. 2025; 5(2):13. https://doi.org/10.3390/nutraceuticals5020013

Chicago/Turabian Style

Streker, Meike, Ehrhardt Proksch, Jan-Christoph Kattenstroth, Burkhard Poeggeler, and Gunter Lemmnitz. 2025. "Comparative Assessment of Nutraceuticals for Supporting Skin Health" Nutraceuticals 5, no. 2: 13. https://doi.org/10.3390/nutraceuticals5020013

APA Style

Streker, M., Proksch, E., Kattenstroth, J.-C., Poeggeler, B., & Lemmnitz, G. (2025). Comparative Assessment of Nutraceuticals for Supporting Skin Health. Nutraceuticals, 5(2), 13. https://doi.org/10.3390/nutraceuticals5020013

Article Metrics

Back to TopTop